To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene OGFOD2andARL6IP4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
709 representative clones for gene OGFOD2andARL6IP4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BC015909 Eye, retinoblastoma .a 1 to 1644 1 to 1644 exact tiling clone, available from MGC, AAA   1644/1644
(100 %)
0 diff
(100 %id)
NM_018694.2   .a 274 to 1651 1 to 1378   RefSeq,   1378/1378
(100 %)
3 diff
(99.8 %id)
BQ668608 epidermoid carcinoma, cell line, salivary gland .a 483 to 946 1 to 464       464/997
(46 %)
15 diff
(98.5 %id)
CR599283 thymus .a 623 to 1613 1 to 991       991/991
(100 %)
0 diff
(100 %id)
BX436897 thymus .a 629 to 1607 8 to 971   fully sequenced,   964/971
(99 %)
26 diff
(97.4 %id)
EB386948 eye, optic nerve .a 641 to 1455 1 to 815       815/815
(100 %)
0 diff
(100 %id)
BG105878 lymph, lymphoma, cell line .a 643 to 1352 1 to 711       711/840
(84 %)
3 diff
(99.7 %id)
BG819260 anaplastic oligodendroglioma with 1p/19qloss, brain .a 643 to 1369 12 to 738       727/738
(98 %)
13 diff
(98.3 %id)
CB992528 placenta, pre-eclamptic placenta .a 644 to 1284 27 to 671       645/860
(75 %)
12 diff
(98.7 %id)
CB961420 placenta, pre-eclamptic placenta .a 644 to 1284 27 to 672       646/788
(81 %)
15 diff
(98.1 %id)
CT003609 T-Lymphocytes .a 645 to 1153 60 to 568       509/571
(89 %)
7 diff
(98.8 %id)
CN336761 embryonic stem cells, cell lines H1, H7, andH9 .a 653 to 1152 1 to 500       500/500
(100 %)
1 diff
(99.8 %id)
BI259538 cervical carcinoma cell line, cervix .a 658 to 1457 1 to 803       803/964
(83 %)
6 diff
(99.4 %id)
CV803535 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 660 to 1354 1 to 691       691/836
(82 %)
7 diff
(99.2 %id)
BG025384 lymph, lymphoma, cell line .a 661 to 1354 1 to 696       696/840
(82 %)
16 diff
(98.1 %id)
TI_149305658   .a 662 to 1412 99 to 849     Submitted on the opposite strand 751/1063
(70 %)
12 diff
(98.9 %id)
BU685978 lung, Primary Lung Epithelial Cells .a 662 to 1404 26 to 767     Submitted on the opposite strand 742/750
(98 %)
10 diff
(98.7 %id)
BG470495 eye, retinoblastoma .a 663 to 1495 1 to 838       838/839
(99 %)
41 diff
(95.2 %id)
CN336764 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 665 to 1197 1 to 533       533/533
(100 %)
0 diff
(100 %id)
DR421759 eye, Pterygium .a 676 to 1314 1 to 639       639/639
(100 %)
1 diff
(99.9 %id)
BE615926 adenocarcinoma, Pancreas .a 680 to 1564 1 to 882       882/919
(95 %)
42 diff
(95.5 %id)
BE254446 eye, retinoblastoma .a 683 to 1165 1 to 484       484/484
(100 %)
1 diff
(99.8 %id)
CN336757 embryonic stem cells, DMSO-treated H9 cellline .a 687 to 1146 1 to 460       460/460
(100 %)
0 diff
(100 %id)
BE888328 leiomyosarcoma, uterus .a 688 to 1348 1 to 656       656/656
(100 %)
7 diff
(99.0 %id)
BE393756 endometrium, adenocarcinoma cell line, uterus .a 689 to 1329 1 to 642       642/679
(94 %)
7 diff
(99.0 %id)
BE889617 leiomyosarcoma, uterus .a 736 to 1531 1 to 794       794/829
(95 %)
18 diff
(97.9 %id)
BG752902 eye, normal pigmented retinal epithelium .a 781 to 1533 1 to 754       754/754
(100 %)
4 diff
(99.5 %id)
TI_227715304   .a 803 to 1644 937 to 106   AAA   832/985
(84 %)
11 diff
(98.9 %id)
BX436896 thymus .a 1105 to 1613 511 to 1   fully sequenced,   511/511
(100 %)
2 diff
(99.7 %id)
DC317389 amygdala .b 1 to 483 6 to 488       488/488
(100 %)
2 diff
(99.6 %id)
DC396343 testis .b 1 to 605 6 to 610   tiling clone,   610/610
(100 %)
1 diff
(99.9 %id)
DC386083   .b 28 to 487 1 to 462       462/462
(100 %)
2 diff
(99.6 %id)
DB009535 colon, tumor tissue .b 416 to 826 2 to 412   tiling clone, capped   411/411
(100 %)
0 diff
(100 %id)
AK074098 Spleen .b 532 to 6149 1 to 5618 exact tiling clone, available from FLJ,   5618/5618
(100 %)
3 diff
(100.0 %id)
AA339215 brain .b 1321 to 1622 1 to 304       304/304
(100 %)
4 diff
(98.7 %id)
BF932943 nervous_tumor .b 2196 to 2339 1 to 144       144/144
(100 %)
1 diff
(99.4 %id)
BG910912 anaplastic oligodendroglioma with 1p/19qloss, brain .b 2221 to 2724 314 to 827       514/833
(61 %)
30 diff
(96.4 %id)
CN337734 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2513 to 3116 1 to 604       604/604
(100 %)
0 diff
(100 %id)
DB541834 hippocampus .b 2704 to 3160 1 to 457     Submitted on the opposite strand 457/457
(100 %)
1 diff
(99.8 %id)
BQ361282 ovary .b 3083 to 3380 1 to 298       298/313
(95 %)
4 diff
(98.8 %id)
AB040953 brain .b 3206 to 5362 2157 to 1   tiling clone, available from KIAA, Submitted on the opposite strand 2157/2157
(100 %)
2 diff
(100.0 %id)
CN337732 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 3600 to 4299 701 to 2     Submitted on the opposite strand 700/701
(99 %)
0 diff
(100 %id)
BG912136 anaplastic oligodendroglioma with 1p/19qloss, brain .b 3768 to 4185 1 to 418       418/418
(100 %)
12 diff
(97.2 %id)
BM150829 leukopheresis .b 3811 to 4256 446 to 1       446/446
(100 %)
0 diff
(100 %id)
TI_57243532   .b 3887 to 4809 28 to 961       934/1006
(92 %)
51 diff
(95.0 %id)
BI915779 brain .b 3892 to 4187 1 to 295       295/295
(100 %)
2 diff
(99.4 %id)
CN337735 embryonic stem cells, cell lines H1, H7, andH9 .b 3902 to 4367 1 to 466       466/466
(100 %)
1 diff
(99.8 %id)
BM151276 leukopheresis .b 3911 to 4256 346 to 1       346/346
(100 %)
14 diff
(96.0 %id)
CN337736 embryonic stem cells, cell lines H1, H7, andH9 .b 4136 to 4257 1 to 122       122/122
(100 %)
0 diff
(100 %id)
BI915979 brain .b 4208 to 5039 1 to 842       842/854
(98 %)
50 diff
(94.2 %id)
TI_57238959   .b 4208 to 5039 32 to 873       842/885
(95 %)
50 diff
(94.4 %id)
BM920986 pooled brain, lung, testis .b 4437 to 4946 70 to 588       519/1367
(37 %)
26 diff
(98.1 %id)
BQ694733 adipose .b 4451 to 4932 1 to 479       479/479
(100 %)
6 diff
(98.8 %id)
AI366206 brain, meningioma .b 4814 to 5256 1 to 443     Submitted on the opposite strand 443/443
(100 %)
3 diff
(99.4 %id)
BX399916 Placenta Cot 25-normalized .b 4840 to 5586 35 to 777       743/777
(95 %)
6 diff
(99.3 %id)
BF877067 lung_tumor .b 5064 to 5552 1 to 489       489/489
(100 %)
2 diff
(99.6 %id)
T56183 ovary .b 5291 to 5592 1 to 312     Submitted on the opposite strand 312/313
(99 %)
17 diff
(94.6 %id)
AA668171   .b 5296 to 5754 9 to 465     Submitted on the opposite strand 457/465
(98 %)
9 diff
(98.1 %id)
AA070224   .b 5307 to 5711 13 to 414     Submitted on the opposite strand 402/424
(94 %)
10 diff
(97.7 %id)
TI_1948084345   .b 5310 to 5833 653 to 126       528/1165
(45 %)
29 diff
(97.6 %id)
AA676459   .b 5332 to 5741 1 to 407     Submitted on the opposite strand 407/407
(100 %)
7 diff
(98.3 %id)
BQ638584 eye, retina .b 5354 to 5902 1 to 549       549/549
(100 %)
1 diff
(99.9 %id)
BM790492 Ascites, stomach .b 5389 to 5953 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
BF850163 lung_normal .b 5393 to 5663 281 to 11     Submitted on the opposite strand 271/281
(96 %)
5 diff
(98.3 %id)
BE693714 breast .b 5403 to 5778 373 to 1       373/373
(100 %)
9 diff
(97.6 %id)
AW380214 head_neck .b 5444 to 5775 338 to 10       329/348
(94 %)
2 diff
(99.5 %id)
AW380212 head_neck .b 5445 to 5786 351 to 6       351/362
(96 %)
8 diff
(97.8 %id)
BQ447676 Knee, Osteoarthritic Cartilage .b 5492 to 6149 670 to 17   AAA   654/654
(100 %)
7 diff
(99.0 %id)
EC465395 Prostate .b 5546 to 5642 1 to 97       97/97
(100 %)
0 diff
(100 %id)
DW437513 Liver .b 5555 to 5780 17 to 242       226/248
(91 %)
8 diff
(96.8 %id)
AA887283 Kidney .b 5871 to 6155 293 to 10   tiling clone,   284/293
(96 %)
0 diff
(100 %id)
BG474240 eye, retinoblastoma .c 1 to 776 1 to 776       776/778
(99 %)
17 diff
(97.9 %id)
EU624490   .c 2 to 1588 1 to 1587 exact tiling clone, AAA   1587/1587
(100 %)
0 diff
(100 %id)
NM_016638.2   .c 275 to 1595 1 to 1321   RefSeq,   1321/1321
(100 %)
3 diff
(99.8 %id)
CF127647 Chondrosarcoma Lung Metastasis cell lines, lung .c 483 to 1192 1 to 710       710/710
(100 %)
3 diff
(99.6 %id)
CB144421 Liver .c 619 to 1084 1 to 466       466/466
(100 %)
2 diff
(99.6 %id)
CB145562 Liver .c 620 to 958 1 to 339       339/339
(100 %)
1 diff
(99.8 %id)
BG542905 lung .c 621 to 704 1 to 84       84/84
(100 %)
1 diff
(98.9 %id)
CN336763 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 632 to 978 1 to 348       348/348
(100 %)
5 diff
(98.6 %id)
CR988774 T-Lymphocytes .c 635 to 1229 1 to 594       594/601
(98 %)
6 diff
(99.1 %id)
CB141858 Liver .c 636 to 962 1 to 327       327/327
(100 %)
2 diff
(99.4 %id)
AB035384   .c 637 to 1588 1 to 952       952/952
(100 %)
1 diff
(99.9 %id)
BI599566 brain, hypothalamus .c 640 to 1134 1 to 494       494/494
(100 %)
6 diff
(98.8 %id)
CN336759 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 642 to 1250 1 to 609       609/609
(100 %)
2 diff
(99.7 %id)
BQ426034 melanotic melanoma, skin .c 643 to 1427 1 to 795       795/942
(84 %)
20 diff
(97.9 %id)
EC443536 Prostate .c 644 to 750 1 to 109       109/109
(100 %)
1 diff
(99.1 %id)
BG109619 Bone, osteosarcoma, cell line .c 644 to 1298 1 to 656       656/664
(98 %)
3 diff
(99.6 %id)
DB489613 hypothalamus .c 645 to 1110 1 to 466       466/466
(100 %)
6 diff
(98.8 %id)
DB498232 hypothalamus .c 645 to 1141 1 to 497       497/497
(100 %)
5 diff
(99.0 %id)
DB503273 hypothalamus .c 645 to 1133 1 to 489       489/489
(100 %)
3 diff
(99.4 %id)
DB504825 hypothalamus .c 645 to 1128 1 to 484       484/484
(100 %)
0 diff
(100 %id)
TI_45212992   .c 645 to 1245 85 to 684       600/684
(87 %)
7 diff
(99.0 %id)
BP324148 Pancreas .c 645 to 1176 1 to 531       531/583
(91 %)
7 diff
(98.8 %id)
AK315759 trachea .c 646 to 1355 1 to 710       710/710
(100 %)
1 diff
(99.9 %id)
BP232121 muscle .c 647 to 1126 1 to 479       479/482
(99 %)
4 diff
(99.2 %id)
DB200232 trachea .c 647 to 1109 2 to 464   capped   463/463
(100 %)
0 diff
(100 %id)
BG748444 eye, normal pigmented retinal epithelium .c 652 to 1361 1 to 716       716/717
(99 %)
11 diff
(98.5 %id)
BM050791 eye, normal pigmented retinal epithelium .c 652 to 1485 1 to 828       828/920
(90 %)
91 diff
(90.2 %id)
CA391295 eye, RPE/choroid .c 653 to 1158 1 to 506       506/506
(100 %)
0 diff
(100 %id)
BQ069107 brain, neuroblastoma, cell line .c 653 to 1508 21 to 875       855/1062
(80 %)
23 diff
(97.9 %id)
BQ918931 large cell carcinoma, lung .c 654 to 1508 1 to 857       857/907
(94 %)
6 diff
(99.4 %id)
DB451115 testis .c 655 to 1131 1 to 478       478/478
(100 %)
2 diff
(99.6 %id)
BE790832 lung, small cell carcinoma .c 657 to 1491 1 to 834       834/836
(99 %)
19 diff
(97.8 %id)
BE272021 adenocarcinoma cell line, ovary .c 661 to 1198 1 to 553       550/553
(99 %)
21 diff
(96.3 %id)
BE783778 eye, retinoblastoma .c 662 to 1361 1 to 697       697/697
(100 %)
3 diff
(99.6 %id)
BQ232986 epithelioid carcinoma, Pancreas .c 663 to 1427 1 to 772       772/850
(90 %)
8 diff
(99.1 %id)
CN336766 embryonic stem cells, DMSO-treated H9 cellline .c 665 to 1200 4 to 541       538/541
(99 %)
7 diff
(98.8 %id)
BJ994883 hepatoblastoma .c 665 to 1080 1 to 416       416/416
(100 %)
0 diff
(100 %id)
CR975683 T-Lymphocytes .c 665 to 1195 1 to 531       531/531
(100 %)
0 diff
(100 %id)
BQ890325 eye, normal pigmented retinal epithelium .c 666 to 1298 1 to 633       633/975
(64 %)
15 diff
(98.5 %id)
AW407016 lymph .c 667 to 982 8 to 323       316/323
(97 %)
6 diff
(98.2 %id)
CB054868 brain, glioblastoma (pooled) .c 667 to 1251 10 to 594   fully sequenced,   585/594
(98 %)
9 diff
(98.5 %id)
BU153708 epithelioid carcinoma, Pancreas .c 667 to 1427 1 to 764       764/913
(83 %)
11 diff
(98.8 %id)
CR988772 T-Lymphocytes .c 667 to 1391 18 to 746       729/747
(97 %)
11 diff
(98.6 %id)
BC001958 Skin, melanotic melanoma. .c 668 to 1586 1 to 919   available from MGC, AAA   919/919
(100 %)
0 diff
(100 %id)
CN336765 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 668 to 1370 7 to 709       703/709
(99 %)
6 diff
(99.2 %id)
BG167559 hypernephroma, cell line, Kidney .c 668 to 1362 1 to 694       692/939
(73 %)
8 diff
(99.2 %id)
BF726010 eye, Iris .c 680 to 797 1 to 118       118/118
(100 %)
0 diff
(100 %id)
BM968212 lung, Primary Lung Epithelial Cells .c 685 to 1374 19 to 709     Submitted on the opposite strand 691/697
(99 %)
4 diff
(99.5 %id)
BM984184 lung, Primary Lung Epithelial Cells .c 685 to 1291 19 to 626     Submitted on the opposite strand 608/608
(100 %)
5 diff
(99.2 %id)
CR622330 B cells (Ramos cell line) Cot 25-normalized .c 686 to 1585 1 to 900       900/900
(100 %)
0 diff
(100 %id)
BE277575 melanotic melanoma, skin .c 686 to 1199 46 to 559       514/559
(91 %)
6 diff
(99.0 %id)
AL582898 B cells from Burkitt lymphoma .c 688 to 1585 1 to 897       897/897
(100 %)
15 diff
(98.4 %id)
BI225409 Burkitt lymphoma, lymph .c 688 to 1436 1 to 759       759/759
(100 %)
32 diff
(95.8 %id)
TI_149273777   .c 688 to 1588 90 to 983   AAA Submitted on the opposite strand 894/983
(90 %)
26 diff
(97.4 %id)
TI_149283769   .c 688 to 1396 82 to 790     Submitted on the opposite strand 709/795
(89 %)
13 diff
(98.4 %id)
BE545360 cervical carcinoma cell line, cervix .c 690 to 1396 1 to 701       701/936
(74 %)
17 diff
(98.2 %id)
CV025964 mixed .c 699 to 1208 1 to 510       510/510
(100 %)
12 diff
(97.7 %id)
BF125058 melanotic melanoma, skin .c 699 to 1298 1 to 607       607/946
(64 %)
19 diff
(98.0 %id)
BU501436 eye, normal pigmented retinal epithelium .c 707 to 1589 1 to 887   AAA   887/887
(100 %)
10 diff
(98.9 %id)
TI_57147188   .c 725 to 1479 27 to 782       756/785
(96 %)
12 diff
(98.5 %id)
BI761306 pooled colon, kidney, stomach .c 733 to 1479 1 to 748       748/751
(99 %)
6 diff
(99.3 %id)
TI_149306815   .c 735 to 1511 77 to 867     Submitted on the opposite strand 791/1083
(73 %)
36 diff
(96.7 %id)
BU686626 lung, Primary Lung Epithelial Cells .c 735 to 1319 21 to 605     Submitted on the opposite strand 585/605
(96 %)
12 diff
(98.1 %id)
CR608335 B cells (Ramos cell line) .c 740 to 1588 1 to 849       849/849
(100 %)
0 diff
(100 %id)
AL560370 B cells (Ramos cell line), B cells from Burkitt lymphoma .c 740 to 1588 1 to 849       849/849
(100 %)
3 diff
(99.7 %id)
BG110613 Bone, osteosarcoma, cell line .c 743 to 1439 1 to 695       695/696
(99 %)
5 diff
(99.3 %id)
AA486219   .c 756 to 960 1 to 205     Submitted on the opposite strand 205/205
(100 %)
1 diff
(99.6 %id)
CR980315 T-Lymphocytes .c 766 to 1586 1 to 821   AAA   821/821
(100 %)
2 diff
(99.8 %id)
BQ941529 large cell carcinoma, lung .c 777 to 1588 1 to 811   AAA   811/811
(100 %)
1 diff
(99.9 %id)
BG574649 breast, mammary adenocarcinoma, cell line .c 785 to 1587 1 to 809       807/828
(97 %)
12 diff
(98.6 %id)
BF338026 brain, glioblastoma with EGFR amplification .c 803 to 1582 1 to 783       783/976
(80 %)
22 diff
(97.8 %id)
BQ270597 insulinoma, Pancreas .c 804 to 1370 1 to 567     Submitted on the opposite strand 567/567
(100 %)
1 diff
(99.9 %id)
BQ549324 insulinoma, Pancreas .c 804 to 1373 1 to 570     Submitted on the opposite strand 570/570
(100 %)
2 diff
(99.7 %id)
BU787410 insulinoma, Pancreas .c 804 to 1395 1 to 592     Submitted on the opposite strand 592/592
(100 %)
1 diff
(99.9 %id)
AW821051 stomach .c 814 to 1020 220 to 15       206/220
(93 %)
0 diff
(100 %id)
BE774161 uterus .c 816 to 1026 231 to 21       211/231
(91 %)
0 diff
(100 %id)
CN336760 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 886 to 1307 1 to 422       422/422
(100 %)
0 diff
(100 %id)
AA158374 Pancreas .c 922 to 1050 1 to 129       129/129
(100 %)
4 diff
(96.9 %id)
AA158375 Pancreas .c 1185 to 1585 403 to 3       401/403
(99 %)
1 diff
(99.8 %id)
CB054867 brain, glioblastoma (pooled) .c 1198 to 1588 425 to 35   fully sequenced, AAA   391/391
(100 %)
0 diff
(100 %id)
F27933 pectoral muscle (after mastectomy) .c 1220 to 1586 1 to 366   AAA   366/366
(100 %)
4 diff
(99.0 %id)
F27927 pectoral muscle (after mastectomy) .c 1223 to 1586 1 to 364       364/364
(100 %)
2 diff
(99.5 %id)
F36692 pectoral muscle (after mastectomy) .c 1223 to 1576 1 to 354       354/354
(100 %)
2 diff
(99.5 %id)
AI264048 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1240 to 1587 348 to 1       348/348
(100 %)
0 diff
(100 %id)
AI720273 colon .c 1242 to 1586 345 to 1       345/345
(100 %)
1 diff
(99.8 %id)
AA468858 colon .c 1266 to 1588 322 to 1       322/322
(100 %)
5 diff
(98.5 %id)
AI569763 anaplastic oligodendroglioma, brain .c 1286 to 1586 301 to 1       301/301
(100 %)
0 diff
(100 %id)
AI971150 Prostate .c 1286 to 1588 303 to 1       303/303
(100 %)
3 diff
(99.1 %id)
BC094839 Brain, neuroblastoma .d 1 to 1354 1 to 1354 S119P tiling clone, AAA   1354/1354
(100 %)
1 diff
(100.0 %id)
BU150659 brain, neuroblastoma, cell line .d 4 to 810 1 to 818       818/974
(83 %)
36 diff
(96.4 %id)
NM_001002251.1   .d 8 to 1361 1 to 1354   RefSeq,   1354/1354
(100 %)
3 diff
(99.8 %id)
BE297898 muscle, rhabdomyosarcoma .d 362 to 951 31 to 635       605/635
(95 %)
19 diff
(97.1 %id)
BF967340 brain, hypothalamus .d 363 to 1137 1 to 779       779/860
(90 %)
25 diff
(97.1 %id)
CD579492 brain .d 363 to 1039 1 to 675       675/869
(77 %)
12 diff
(98.7 %id)
CD579510 brain .d 363 to 1039 1 to 675       675/869
(77 %)
12 diff
(98.7 %id)
BF204494 muscle, rhabdomyosarcoma .d 367 to 995 1 to 631       631/644
(97 %)
27 diff
(95.9 %id)
BI114111 muscle, rhabdomyosarcoma .d 367 to 755 1 to 392       392/1021
(38 %)
11 diff
(99.0 %id)
DB485873 hypothalamus .d 370 to 809 1 to 438       438/438
(100 %)
9 diff
(98.0 %id)
DB486029 hypothalamus .d 370 to 647 1 to 280       280/360
(77 %)
8 diff
(97.8 %id)
BU553829 ovary, teratocarcinoma, cell line .d 382 to 1271 1 to 908       908/934
(97 %)
33 diff
(96.5 %id)
BQ226426 large cell carcinoma, lung .d 383 to 1233 1 to 857       857/868
(98 %)
17 diff
(98.1 %id)
BF237967 leiomyosarcoma cell line, uterus .d 385 to 940 1 to 570       570/1116
(51 %)
33 diff
(97.1 %id)
BI838334 pooled pancreas and spleen .d 385 to 1221 1 to 834       834/834
(100 %)
8 diff
(99.1 %id)
TI_57162973   .d 385 to 1221 36 to 869       834/869
(95 %)
14 diff
(98.4 %id)
BQ711564 Spleen .d 387 to 1193 1 to 818       818/981
(83 %)
27 diff
(97.3 %id)
BQ927494 carcinoma, cell line, Prostate .d 387 to 1281 1 to 912       912/943
(96 %)
41 diff
(95.7 %id)
BQ935674 carcinoma, cell line, Prostate .d 387 to 1277 1 to 895       895/935
(95 %)
22 diff
(97.7 %id)
BE383182 brain, neuroblastoma .d 388 to 1064 1 to 672       672/726
(92 %)
6 diff
(99.2 %id)
BG474570 eye, retinoblastoma .d 390 to 961 1 to 576       576/576
(100 %)
10 diff
(98.3 %id)
BM043071 carcinoma, cell line, Prostate .d 390 to 995 1 to 611       611/756
(80 %)
12 diff
(98.5 %id)
BG034721 breast, mammary adenocarcinoma, cell line .d 391 to 1128 1 to 737       737/751
(98 %)
5 diff
(99.4 %id)
BM051282 eye, normal pigmented retinal epithelium .d 391 to 800 1 to 414       414/901
(45 %)
17 diff
(98.2 %id)
BU188353 melanotic melanoma, skin .d 391 to 1064 1 to 676       676/964
(70 %)
9 diff
(99.1 %id)
BU162577 melanotic melanoma, cell line, skin .d 398 to 1147 1 to 760       760/902
(84 %)
22 diff
(97.6 %id)
AI752542 Bone, Hip .d 400 to 738 9 to 347       339/347
(97 %)
0 diff
(100 %id)
BE896812 melanotic melanoma, skin .d 418 to 873 1 to 439       439/617
(71 %)
9 diff
(98.6 %id)
CR625814 Placenta Cot 25-normalized .d 419 to 1353 1 to 935       935/935
(100 %)
0 diff
(100 %id)
BX417067 placenta .d 419 to 1353 1 to 934       934/934
(100 %)
2 diff
(99.8 %id)
BX378339 Placenta Cot 25-normalized .d 419 to 1351 1 to 924   fully sequenced,   924/924
(100 %)
14 diff
(98.5 %id)
BE266212 lung, small cell carcinoma .d 419 to 1055 1 to 648       648/648
(100 %)
16 diff
(97.6 %id)
BE265087 lung, small cell carcinoma .d 419 to 1059 1 to 641       641/643
(99 %)
3 diff
(99.6 %id)
BE392755 endometrium, adenocarcinoma cell line, uterus .d 419 to 1079 1 to 659       659/660
(99 %)
12 diff
(98.2 %id)
BE794181 lung, small cell carcinoma .d 419 to 1292 1 to 867       867/869
(99 %)
25 diff
(97.2 %id)
BE408431 choriocarcinoma, placenta .d 420 to 997 1 to 578       578/578
(100 %)
0 diff
(100 %id)
BE900397 choriocarcinoma, placenta .d 421 to 1122 1 to 699       699/699
(100 %)
4 diff
(99.5 %id)
BQ927874 carcinoma, cell line, Prostate .d 424 to 1064 1 to 645       645/970
(66 %)
10 diff
(99.0 %id)
EF036485   .d 447 to 718 1 to 272       272/272
(100 %)
0 diff
(100 %id)
TI_149314348   .d 449 to 1354 978 to 82   AAA   897/984
(91 %)
15 diff
(98.5 %id)
BU951090 Pancreas, Purified pancreatic islet .d 465 to 961 1 to 497   fully sequenced,   497/497
(100 %)
0 diff
(100 %id)
BF850031 lung_normal .d 481 to 942 462 to 1     Submitted on the opposite strand 462/462
(100 %)
0 diff
(100 %id)
ES309198 occipital hair of pubic hypotrichosispatient, skin .d 497 to 993 1 to 500       500/670
(74 %)
14 diff
(98.0 %id)
BQ430962 large cell carcinoma, lung .d 502 to 1306 24 to 835       812/1109
(73 %)
30 diff
(97.3 %id)
BM704996 eye, lens .d 508 to 925 1 to 418       418/418
(100 %)
2 diff
(99.6 %id)
CN274246 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 526 to 748 1 to 223       223/223
(100 %)
2 diff
(99.2 %id)
AI459511 brain, oligodendroglioma .d 533 to 860 1 to 328     Submitted on the opposite strand 328/328
(100 %)
3 diff
(99.1 %id)
BQ130497 insulinoma, Pancreas .d 536 to 1082 1 to 547     Submitted on the opposite strand 547/547
(100 %)
3 diff
(99.5 %id)
BQ272300 insulinoma, Pancreas .d 537 to 1082 1 to 546     Submitted on the opposite strand 546/546
(100 %)
1 diff
(99.9 %id)
BQ267393 insulinoma, Pancreas .d 537 to 1082 1 to 546     Submitted on the opposite strand 546/546
(100 %)
1 diff
(99.9 %id)
BE736254 adenocarcinoma, Pancreas .d 548 to 1335 1 to 779       779/781
(99 %)
20 diff
(97.5 %id)
BF969828 adrenal cortex carcinoma, cell line, adrenal gland .d 589 to 1313 1 to 752       725/1222
(59 %)
30 diff
(97.6 %id)
BU526490 epidermoid carcinoma, cell line, lung .d 591 to 1354 9 to 772       764/952
(80 %)
6 diff
(99.4 %id)
BG111381 Bone, osteosarcoma, cell line .d 592 to 1128 1 to 542       542/1344
(40 %)
8 diff
(99.5 %id)
TI_154045202   .d 597 to 1354 837 to 85   AAA   753/936
(80 %)
12 diff
(98.8 %id)
CD365780 Alveolar Macrophage, lung .d 601 to 1354 768 to 19   AAA   750/750
(100 %)
4 diff
(99.5 %id)
BQ640106 eye, retina .d 610 to 1231 1 to 622       622/622
(100 %)
0 diff
(100 %id)
BM713541 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 611 to 1025 1 to 415   fully sequenced,   415/415
(100 %)
1 diff
(99.8 %id)
BU786073 insulinoma, Pancreas .d 631 to 1209 41 to 619     Submitted on the opposite strand 579/619
(93 %)
6 diff
(99.1 %id)
CB306012 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 672 to 1354 699 to 17   AAA   683/683
(100 %)
0 diff
(100 %id)
BU616800 Cell Line, Chondrosarcoma .d 674 to 1354 697 to 17   AAA   681/681
(100 %)
2 diff
(99.8 %id)
CA412044 Chondrosarcoma Grade II, Left Pelvis .d 680 to 1354 693 to 19   AAA   675/675
(100 %)
1 diff
(99.9 %id)
TI_149280464   .d 681 to 1350 795 to 126       670/796
(84 %)
2 diff
(99.8 %id)
BQ641858 eye, normal pigmented retinal epithelium .d 690 to 1352 1 to 663   AAA   663/663
(100 %)
4 diff
(99.4 %id)
BM559502 amelanotic melanoma, cell line, skin .d 692 to 1354 1 to 663       663/1080
(61 %)
1 diff
(100.0 %id)
BQ882613 Spleen .d 692 to 1354 1 to 663   AAA   663/663
(100 %)
1 diff
(99.9 %id)
BM810761 amelanotic melanoma, cell line, skin .d 693 to 1354 1 to 672       672/1143
(58 %)
30 diff
(97.4 %id)
BQ065401 lymph, lymphoma, cell line .d 693 to 1352 1 to 660   AAA   660/660
(100 %)
1 diff
(99.9 %id)
BU622322 Cell Line, Chondrosarcoma .d 693 to 1354 678 to 17   AAA   662/662
(100 %)
0 diff
(100 %id)
BY797772 eye .d 694 to 1269 1 to 576       576/576
(100 %)
2 diff
(99.7 %id)
TI_154023823   .d 698 to 1354 691 to 30   AAA   662/723
(91 %)
26 diff
(96.5 %id)
BU633620 cell lines, Chondrosarcoma .d 708 to 1354 665 to 19   AAA   647/647
(100 %)
0 diff
(100 %id)
BG751950 eye, normal pigmented retinal epithelium .d 709 to 1354 1 to 646       646/666
(96 %)
1 diff
(99.9 %id)
BF793094 adrenal cortex carcinoma, cell line, adrenal gland .d 710 to 1355 1 to 644       644/1118
(57 %)
4 diff
(99.7 %id)
BU631445 cell lines, Chondrosarcoma .d 716 to 1354 657 to 19   AAA   639/639
(100 %)
1 diff
(99.9 %id)
BU632483 cell lines, Chondrosarcoma .d 716 to 1354 657 to 19   AAA   639/639
(100 %)
0 diff
(100 %id)
AW380336 head_neck .d 719 to 1101 1 to 384       384/386
(99 %)
15 diff
(96.2 %id)
BE383225 brain, neuroblastoma .d 723 to 1354 1 to 630   AAA   630/630
(100 %)
2 diff
(99.7 %id)
BU674689 lung, Primary Lung Epithelial Cells .d 725 to 1354 646 to 17   AAA   630/630
(100 %)
0 diff
(100 %id)
BM009680 amelanotic melanoma, cell line, skin .d 731 to 1354 1 to 622   AAA   622/622
(100 %)
5 diff
(99.2 %id)
TI_59384447   .d 731 to 1354 56 to 677   AAA   622/622
(100 %)
5 diff
(99.2 %id)
BU679243 lung, Primary Lung Epithelial Cells .d 735 to 1350 638 to 23       616/638
(96 %)
0 diff
(100 %id)
BQ001689 lung, Metastatic Chondrosarcoma .d 737 to 1354 634 to 17   AAA   618/630
(98 %)
1 diff
(99.9 %id)
BU947280 insulinoma, Pancreas .d 737 to 1358 626 to 5     Submitted on the opposite strand 622/626
(99 %)
1 diff
(99.9 %id)
BU948976 Pancreas, Purified pancreatic islet .d 748 to 1025 1 to 278   fully sequenced,   278/278
(100 %)
0 diff
(100 %id)
BM793504 Ascites, stomach .d 753 to 1345 1 to 593       593/593
(100 %)
0 diff
(100 %id)
AW605975 head_neck .d 754 to 1101 7 to 357       351/359
(97 %)
14 diff
(96.2 %id)
BQ270189 insulinoma, Pancreas .d 755 to 1347 594 to 2     Submitted on the opposite strand 593/594
(99 %)
0 diff
(100 %id)
BU787688 insulinoma, Pancreas .d 756 to 1328 580 to 8     Submitted on the opposite strand 573/580
(98 %)
0 diff
(100 %id)
BM717502 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 756 to 1352 1 to 597   AAA   597/597
(100 %)
1 diff
(99.9 %id)
BM546916 ovary (pool of 3) .d 760 to 1354 21 to 615       595/619
(96 %)
7 diff
(98.9 %id)
BM906806 ovary (pool of 3) .d 760 to 1354 13 to 608       596/635
(93 %)
8 diff
(98.8 %id)
BQ772618 Chondrosarcoma Cell line .d 760 to 1352 607 to 17   AAA   593/601
(98 %)
3 diff
(99.6 %id)
BQ670852 epidermoid carcinoma, cell line, salivary gland .d 764 to 1279 1 to 516       516/520
(99 %)
1 diff
(99.9 %id)
BG110393 Bone, osteosarcoma, cell line .d 765 to 1354 1 to 590   AAA   590/590
(100 %)
0 diff
(100 %id)
BM705023 eye, lens .d 767 to 1272 1 to 506       506/506
(100 %)
0 diff
(100 %id)
BQ130750 insulinoma, Pancreas .d 771 to 1339 576 to 8     Submitted on the opposite strand 569/576
(98 %)
4 diff
(99.4 %id)
TI_159696541   .d 772 to 1352 689 to 109   AAA   581/807
(71 %)
1 diff
(99.9 %id)
CN480553 Cell Line, Chondrosarcoma .d 772 to 1352 597 to 17   AAA   581/590
(98 %)
1 diff
(99.9 %id)
AW571757 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 775 to 1354 589 to 10       580/589
(98 %)
9 diff
(98.5 %id)
BE898118 melanotic melanoma, skin .d 785 to 1351 1 to 580       580/580
(100 %)
17 diff
(97.1 %id)
BE897853 melanotic melanoma, skin .d 785 to 1348 1 to 564       564/566
(99 %)
1 diff
(99.9 %id)
BM793598 Ascites, stomach .d 785 to 1243 1 to 459       459/459
(100 %)
0 diff
(100 %id)
TI_151717327   .d 796 to 1352 667 to 108   AAA   560/955
(58 %)
12 diff
(98.8 %id)
AA523399 lung, lung tumor .d 813 to 1354 542 to 3       540/546
(98 %)
3 diff
(99.5 %id)
BQ267691 insulinoma, Pancreas .d 813 to 1337 532 to 8     Submitted on the opposite strand 525/532
(98 %)
2 diff
(99.7 %id)
BQ581151 insulinoma, Pancreas .d 813 to 1354 565 to 24   AAA Submitted on the opposite strand 542/542
(100 %)
0 diff
(100 %id)
BF525431 brain, glioblastoma with EGFR amplification .d 823 to 1354 1 to 533   AAA   533/533
(100 %)
2 diff
(99.7 %id)
AA316945 colon .d 826 to 1236 1 to 411       411/411
(100 %)
0 diff
(100 %id)
BP390526 pancreatic islet .d 828 to 1247 420 to 1       420/420
(100 %)
0 diff
(100 %id)
BQ270841 insulinoma, Pancreas .d 829 to 1328 507 to 8     Submitted on the opposite strand 500/507
(98 %)
0 diff
(100 %id)
BQ018325 lung, Metastatic Chondrosarcoma .d 835 to 1354 536 to 17   AAA   520/520
(100 %)
0 diff
(100 %id)
BQ319419 colon .d 846 to 1186 1 to 343       343/343
(100 %)
12 diff
(96.6 %id)
AI361248 brain, glioblastoma (pooled) .d 846 to 1352 507 to 1       507/507
(100 %)
1 diff
(99.9 %id)
EL945853 eyeball .d 851 to 1099 1 to 248       248/248
(100 %)
2 diff
(99.2 %id)
BG709373 brain, hypothalamus .d 857 to 1354 1 to 497   AAA   497/497
(100 %)
4 diff
(99.2 %id)
AI955271 brain, four pooled pituitary adenomas .d 863 to 1354 509 to 18   AAA   492/492
(100 %)
1 diff
(99.8 %id)
BU564691 mixed (pool of 40 RNAs) .d 871 to 1354 1 to 478       478/514
(92 %)
7 diff
(98.7 %id)
F31334 pectoral muscle (after mastectomy) .d 872 to 1154 1 to 282       282/282
(100 %)
2 diff
(99.3 %id)
BQ319418 colon .d 873 to 1124 256 to 1       256/259
(98 %)
10 diff
(96.2 %id)
EL948045 eyeball .d 873 to 1354 52 to 530   AAA   479/530
(90 %)
6 diff
(98.9 %id)
DB576083 hypothalamus .d 873 to 1354 1 to 482     Submitted on the opposite strand 482/491
(98 %)
1 diff
(99.8 %id)
DB367959.
matches multiple genes
  .d 873 to 1358 486 to 1     also hits gene DPYSL2 486/531
(91 %)
3 diff
(99.5 %id)
BF759244 colon .d 875 to 1163 292 to 1     Submitted on the opposite strand 292/292
(100 %)
11 diff
(96.3 %id)
AW173463 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 880 to 1354 475 to 1       475/475
(100 %)
0 diff
(100 %id)
AW440397 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 887 to 1353 470 to 3       468/470
(99 %)
0 diff
(100 %id)
DB576465 hypothalamus .d 888 to 1354 1 to 467     Submitted on the opposite strand 467/467
(100 %)
3 diff
(99.4 %id)
CR624619 Neuroblastoma Cot 50-normalized .d 900 to 1354 1 to 455       455/455
(100 %)
0 diff
(100 %id)
BX333972 Neuroblastoma Cot 50-normalized .d 900 to 1354 1 to 455   fully sequenced,   455/455
(100 %)
2 diff
(99.6 %id)
BM970197 lung .d 900 to 1354 471 to 17   AAA   455/463
(98 %)
0 diff
(100 %id)
AI674713 pooled .d 902 to 1353 457 to 5       453/457
(99 %)
1 diff
(99.8 %id)
DB569327 hypothalamus .d 903 to 1354 1 to 452   AAA Submitted on the opposite strand 452/452
(100 %)
9 diff
(98.1 %id)
AI122765 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 903 to 1353 451 to 1       451/451
(100 %)
0 diff
(100 %id)
DB566492 hypothalamus .d 905 to 1352 1 to 448     Submitted on the opposite strand 448/448
(100 %)
1 diff
(99.8 %id)
AI589509 anaplastic oligodendroglioma, brain .d 906 to 1353 448 to 1       448/448
(100 %)
1 diff
(99.8 %id)
AW304159 lung, two pooled squamous cell carcinomas .d 906 to 1354 450 to 2       449/450
(99 %)
0 diff
(100 %id)
BQ016450 lung, Metastatic Chondrosarcoma .d 906 to 1352 467 to 21       447/475
(94 %)
0 diff
(100 %id)
AI799638 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 908 to 1352 445 to 1       445/445
(100 %)
2 diff
(99.6 %id)
AI954156 normal epithelium, ovary .d 908 to 1354 458 to 12   AAA   447/447
(100 %)
0 diff
(100 %id)
AI860591 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 909 to 1354 448 to 3       446/448
(99 %)
0 diff
(100 %id)
DB516609 testis .d 911 to 1352 1 to 442     Submitted on the opposite strand 442/442
(100 %)
0 diff
(100 %id)
AI342142 uterus .d 911 to 1354 444 to 1       444/444
(100 %)
0 diff
(100 %id)
AA533128 normal prostatic epithelial cells, Prostate .d 912 to 1354 466 to 26   AAA   441/447
(98 %)
28 diff
(93.8 %id)
AA588052 colon, tumor .d 913 to 1354 441 to 1       441/441
(100 %)
1 diff
(99.8 %id)
BX113885 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 914 to 1352 453 to 15   AAA   439/439
(100 %)
0 diff
(100 %id)
AA617659 lung, lung tumor .d 915 to 1324 411 to 2       410/411
(99 %)
1 diff
(99.8 %id)
BP387465 pancreatic islet .d 917 to 1352 53 to 488     Submitted on the opposite strand 436/488
(89 %)
5 diff
(99.0 %id)
BE540817 cervix .d 918 to 1350 1 to 436       436/436
(100 %)
3 diff
(99.4 %id)
BG059621 brain, glioblastoma without EGFR amplification .d 918 to 1354 437 to 1       437/437
(100 %)
0 diff
(100 %id)
GD136122   .d 920 to 1354 1 to 433       433/441
(98 %)
12 diff
(97.3 %id)
DB574505 hypothalamus .d 921 to 1354 1 to 434     Submitted on the opposite strand 434/443
(97 %)
1 diff
(99.8 %id)
AI916462 adenocarcinoma, Pancreas .d 921 to 1352 447 to 16   AAA   432/432
(100 %)
0 diff
(100 %id)
BF759277 colon .d 924 to 1245 1 to 322       322/327
(98 %)
9 diff
(97.3 %id)
BU952530 Pancreas, Purified pancreatic islet .d 931 to 1354 429 to 6   fully sequenced,   424/429
(98 %)
1 diff
(99.8 %id)
BF759262 colon .d 938 to 1168 231 to 1     Submitted on the opposite strand 231/231
(100 %)
4 diff
(98.3 %id)
AA070326   .d 943 to 1354 416 to 4     Submitted on the opposite strand 413/441
(93 %)
5 diff
(98.9 %id)
BU688031 lung .d 959 to 1352 410 to 17   AAA   394/417
(94 %)
0 diff
(100 %id)
BX330072 Placenta Cot 25-normalized .d 964 to 1353 389 to 1   fully sequenced,   389/389
(100 %)
4 diff
(99.0 %id)
BU948724 Pancreas, Purified pancreatic islet .d 964 to 1353 390 to 1   fully sequenced,   390/390
(100 %)
0 diff
(100 %id)
BU739568 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 964 to 1354 407 to 17   fully sequenced, AAA   391/391
(100 %)
0 diff
(100 %id)
AW189362 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 978 to 1358 382 to 4       379/382
(99 %)
1 diff
(99.8 %id)
F25803 pectoral muscle (after mastectomy) .d 990 to 1270 1 to 281       281/281
(100 %)
0 diff
(100 %id)
BE909684 epithelioid carcinoma, Pancreas .d 991 to 1349 1 to 359       359/359
(100 %)
2 diff
(99.5 %id)
BX392387 Neuroblastoma Cot 50-normalized .d 1014 to 1353 339 to 1   fully sequenced,   339/339
(100 %)
6 diff
(98.3 %id)
NM_001002252.1   .e 1 to 1402 1 to 1402 exact RefSeq,   1402/1402
(100 %)
3 diff
(99.8 %id)
BC015569 Uterus, endometrium adenocarcinoma .e 398 to 1393 1 to 996   tiling clone, available from MGC, AAA   996/996
(100 %)
0 diff
(100 %id)
BE379413 endometrium, adenocarcinoma cell line, uterus .e 412 to 1203 44 to 834       791/845
(93 %)
9 diff
(99.0 %id)
CV028939 mixed .e 425 to 1055 1 to 629       629/629
(100 %)
9 diff
(98.6 %id)
TI_1948084899   .e 489 to 1077 713 to 125       589/1482
(39 %)
28 diff
(98.2 %id)
BI090609 cervix .e 826 to 1394 1 to 569       569/587
(96 %)
2 diff
(99.7 %id)
BF759291 colon .e 833 to 1139 6 to 310       305/310
(98 %)
8 diff
(97.5 %id)
AW973635   .e 897 to 1392 496 to 1     Submitted on the opposite strand 496/496
(100 %)
7 diff
(98.6 %id)
AI888935 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 899 to 1394 497 to 2       496/497
(99 %)
0 diff
(100 %id)
BU175071 epidermoid carcinoma, cell line, salivary gland .e 905 to 1395 21 to 511   tiling clone, AAA   491/511
(96 %)
6 diff
(98.9 %id)
BQ671741 epidermoid carcinoma, cell line, salivary gland .e 911 to 1399 1 to 491       491/1148
(42 %)
6 diff
(99.5 %id)
BE047483 ovary, serous papillary tumor .e 942 to 1395 462 to 9       454/462
(98 %)
0 diff
(100 %id)
AW008080 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 957 to 1395 454 to 16   AAA   439/439
(100 %)
5 diff
(98.9 %id)
DN995613 breast cancer, Mammary gland (cancer tissue) .e 958 to 1393 1 to 436   AAA   436/436
(100 %)
5 diff
(98.9 %id)
AA147366   .e 961 to 1393 433 to 1       433/433
(100 %)
5 diff
(98.9 %id)
AW439468 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 1027 to 1395 375 to 9       367/375
(97 %)
0 diff
(100 %id)
AI084216 B-cell, chronic lymphotic leukemia .e 1041 to 1395 375 to 21   AAA   355/355
(100 %)
1 diff
(99.8 %id)
AA371960 pituitary gland .e 1044 to 1393 1 to 350       350/350
(100 %)
0 diff
(100 %id)
AA371961 pituitary gland .e 1044 to 1393 1 to 350       350/350
(100 %)
0 diff
(100 %id)
AA557570 colon .e 1053 to 1394 343 to 4       340/343
(99 %)
0 diff
(100 %id)
AJ573801 pectoral muscle (after mastectomy) .e 1104 to 1397 15 to 308   AAA   294/308
(95 %)
5 diff
(98.4 %id)
BM857759 insulinoma, Pancreas .e 1104 to 1393 9 to 298   AAA   290/298
(97 %)
6 diff
(98.0 %id)
BM695950 eye, human retina .e 1110 to 1395 1 to 286   AAA   286/286
(100 %)
0 diff
(100 %id)
AW168690 bowel (skin primary), metastatic melanoma to bowel .e 1130 to 1395 267 to 1       267/267
(100 %)
1 diff
(99.7 %id)
BQ010523 placenta .e 1131 to 1393 280 to 18   AAA   263/263
(100 %)
4 diff
(98.5 %id)
AI301776 carcinoid, lung .e 1133 to 1394 264 to 3       262/264
(99 %)
0 diff
(100 %id)
AI453265 adenocarcinoma, Pancreas .e 1133 to 1395 265 to 3       263/265
(99 %)
0 diff
(100 %id)
BG289377 bladder, transitional cell papilloma, cell line .e 1133 to 1395 1 to 262   AAA   262/262
(100 %)
1 diff
(99.7 %id)
AA371829 pituitary gland .e 1146 to 1395 250 to 1     Submitted on the opposite strand 250/250
(100 %)
0 diff
(100 %id)
AA743899 Kidney .e 1149 to 1393 266 to 24   AAA   243/243
(100 %)
3 diff
(98.8 %id)
AA514219 colon .e 1175 to 1395 220 to 1       220/221
(99 %)
1 diff
(99.6 %id)
AA740682 2 pooled tumors (clear cell type), Kidney .e 1175 to 1395 223 to 4       220/223
(98 %)
0 diff
(100 %id)
BG944525 blood .e 1193 to 1395 233 to 31   AAA   203/203
(100 %)
3 diff
(98.6 %id)
AA114001   .e 1205 to 1379 173 to 1     Submitted on the opposite strand 173/173
(100 %)
2 diff
(98.9 %id)
BF973904 leiomyosarcoma cell line, uterus .e 1215 to 1393 1 to 179   AAA   179/179
(100 %)
0 diff
(100 %id)
DB515403 testis .e 1247 to 1393 10 to 157     Submitted on the opposite strand 148/157
(94 %)
6 diff
(96.2 %id)
BI520720 brain, medulla .e 1257 to 1318 62 to 1       62/62
(100 %)
0 diff
(100 %id)
BP279509   .f 1 to 563 1 to 564   tiling clone,   564/565
(99 %)
4 diff
(99.3 %id)
BI911669 leukocyte .f 526 to 1136 33 to 668       608/889
(68 %)
36 diff
(96.0 %id)
TI_57233480   .f 526 to 1136 33 to 668       608/889
(68 %)
36 diff
(96.0 %id)
AK094820 brain .f 529 to 2308 1 to 1780 exact tiling clone, available from FLJ,   1780/1780
(100 %)
1 diff
(100.0 %id)
DA208736 brain .f 530 to 751 2 to 223   capped   222/222
(100 %)
0 diff
(100 %id)
DB045446 testis .f 530 to 1094 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
CF140204 CNCAP(3)T-225 cell line, Prostate .f 531 to 1105 8 to 582       575/582
(98 %)
6 diff
(99.0 %id)
TI_154170628   .f 531 to 1291 80 to 830       751/822
(91 %)
23 diff
(97.3 %id)
BI762747 pooled colon, kidney, stomach .f 539 to 1426 1 to 897       897/919
(97 %)
20 diff
(97.9 %id)
TI_57150410   .f 539 to 1426 68 to 964       897/986
(90 %)
25 diff
(97.5 %id)
BX640675 colon endothel, primary cell culture .f 540 to 1719 1 to 1180 N244S tiling clone, available from DKFZ, AAA   1180/1180
(100 %)
2 diff
(99.9 %id)
BE270463 Burkitt lymphoma, lymph .f 542 to 1189 26 to 672       647/673
(96 %)
7 diff
(99.0 %id)
BE397375 Burkitt lymphoma, lymph .f 542 to 1338 18 to 806       789/870
(90 %)
20 diff
(97.8 %id)
CN337733 embryonic stem cells, DMSO-treated H9 cellline .f 548 to 1058 1 to 511       511/511
(100 %)
2 diff
(99.7 %id)
BP330828 rectum .f 549 to 1130 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BM920456 pooled lung and spleen .f 550 to 1515 1 to 985       985/1118
(88 %)
30 diff
(97.4 %id)
BF185065 bone marrow, from chronic myelogenous leukemia .f 552 to 1160 1 to 617       615/1047
(58 %)
23 diff
(97.9 %id)
CX870960 embryonic stem .f 552 to 1314 1 to 763       763/763
(100 %)
0 diff
(100 %id)
DA678566   .f 552 to 1118 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB023877 testis .f 552 to 1110 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BP299927   .f 553 to 1133 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA060410 cerebellum .f 554 to 1119 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA277322 corpus callosum .f 554 to 1110 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA344308 substantia nigra .f 554 to 1048 2 to 497   capped   496/496
(100 %)
1 diff
(99.8 %id)
DA632297 Kidney .f 554 to 1138 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
CB142899 Liver .f 556 to 1032 1 to 477       477/477
(100 %)
2 diff
(99.6 %id)
DB046560 testis .f 558 to 1122 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA264069 caudate nucleus .f 559 to 1113 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BM913678 astrocytoma grade IV, cell line, brain .f 559 to 864 1 to 306       306/707
(43 %)
1 diff
(99.9 %id)
TI_57177366   .f 561 to 1373 62 to 878       817/878
(93 %)
15 diff
(98.3 %id)
BI830872 brain, medulla .f 563 to 1373 1 to 815       815/815
(100 %)
7 diff
(99.2 %id)
AW630098 2 pooled high-grade transitional celltumors, genitourinary tract .f 567 to 686 1 to 120       120/120
(100 %)
0 diff
(100 %id)
BE779691 eye, retinoblastoma .f 571 to 1227 1 to 664       664/721
(92 %)
14 diff
(98.1 %id)
TI_57170131   .f 571 to 1558 29 to 1009       981/1073
(91 %)
38 diff
(96.5 %id)
BI825248 brain, medulla .f 572 to 1558 1 to 980       980/1044
(93 %)
32 diff
(97.0 %id)
DN602277 human embryonic stem cells .f 572 to 1365 20 to 813       794/813
(97 %)
6 diff
(99.3 %id)
BM457943 leiomyosarcoma, uterus .f 573 to 1085 1 to 513       513/1435
(35 %)
6 diff
(99.6 %id)
TI_59390853   .f 574 to 1395 95 to 918       824/825
(99 %)
8 diff
(99.1 %id)
BM020074 astrocytoma grade IV, cell line, brain .f 575 to 1395 1 to 823       823/824
(99 %)
8 diff
(99.1 %id)
BM044979 carcinoma, cell line, Prostate .f 575 to 1513 1 to 930       930/932
(99 %)
19 diff
(98.0 %id)
TI_57236322   .f 575 to 1240 28 to 716       660/861
(76 %)
54 diff
(93.8 %id)
BM560742 astrocytoma grade IV, cell line, brain .f 576 to 1347 1 to 773       773/1069
(72 %)
18 diff
(98.4 %id)
CR985644 T-Lymphocytes .f 576 to 743 1 to 169       169/170
(99 %)
5 diff
(97.1 %id)
BM910358 astrocytoma grade IV, cell line, brain .f 577 to 1447 1 to 884       883/1052
(83 %)
19 diff
(98.2 %id)
BU197265 epidermoid carcinoma, cell line, salivary gland .f 579 to 1479 1 to 918       918/926
(99 %)
27 diff
(97.1 %id)
BU163738 epidermoid carcinoma, cell line, salivary gland .f 579 to 1344 1 to 771       771/943
(81 %)
12 diff
(98.8 %id)
BU191556 epidermoid carcinoma, cell line, salivary gland .f 579 to 1425 1 to 853       852/904
(94 %)
27 diff
(97.1 %id)
BQ670612 epidermoid carcinoma, cell line, salivary gland .f 579 to 1098 1 to 520       520/1157
(44 %)
5 diff
(99.6 %id)
CB594868 Blood, promyelocytic leukemia .f 579 to 1447 1 to 875       875/876
(99 %)
10 diff
(98.9 %id)
BI907933 leukocyte .f 580 to 1240 1 to 684       655/829
(79 %)
51 diff
(93.9 %id)
AA354016   .f 581 to 775 1 to 193       193/193
(100 %)
4 diff
(98.0 %id)
BU526554 epidermoid carcinoma, cell line, lung .f 581 to 1493 9 to 922       914/922
(99 %)
9 diff
(99.1 %id)
BP367015 thymus .f 586 to 1166 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DA617604   .f 613 to 1189 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
BP297107   .f 620 to 1192 1 to 573       573/581
(98 %)
3 diff
(99.5 %id)
CN337730 embryonic stem cells, DMSO-treated H9 cellline .f 629 to 995 1 to 367       367/367
(100 %)
0 diff
(100 %id)
BG397649 B-cells, primary B-cells from tonsils (cell line) .f 668 to 1558 1 to 885       885/939
(94 %)
24 diff
(97.5 %id)
CA312112 Human Lung Epithelial cells, lung .f 1724 to 2308 600 to 16   AAA   585/585
(100 %)
1 diff
(99.9 %id)
BM725643 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 1727 to 1808 1 to 82   fully sequenced,   82/82
(100 %)
0 diff
(100 %id)
DB304292 brain .f 1778 to 2308 531 to 1       531/531
(100 %)
0 diff
(100 %id)
BM678254 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 1778 to 2308 549 to 19   fully sequenced, AAA   531/531
(100 %)
0 diff
(100 %id)
DB570039 hypothalamus .f 1806 to 2308 1 to 504     Submitted on the opposite strand 504/504
(100 %)
9 diff
(98.3 %id)
DB524579 testis .f 1828 to 2308 1 to 481     Submitted on the opposite strand 481/481
(100 %)
0 diff
(100 %id)
AW613282 2 pooled high-grade transitional celltumors, genitourinary tract .f 1830 to 2309 485 to 6       480/485
(98 %)
0 diff
(100 %id)
BG060159 brain, glioblastoma without EGFR amplification .f 1835 to 2311 478 to 2       477/478
(99 %)
0 diff
(100 %id)
AW197006 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .f 1837 to 2308 472 to 1       472/472
(100 %)
2 diff
(99.6 %id)
BE933227 head_neck .f 1848 to 2284 439 to 3       437/439
(99 %)
0 diff
(100 %id)
DB565319 hypothalamus .f 1858 to 2308 1 to 451     Submitted on the opposite strand 451/451
(100 %)
1 diff
(99.8 %id)
DB520957 testis .f 1863 to 2309 1 to 447     Submitted on the opposite strand 447/449
(99 %)
1 diff
(99.8 %id)
DB512413 testis .f 1912 to 2308 3 to 400     Submitted on the opposite strand 398/400
(99 %)
18 diff
(95.5 %id)
BX093055 whole brain .f 1920 to 2308 403 to 15   AAA   389/389
(100 %)
1 diff
(99.8 %id)
AA531120 normal prostatic epithelial cells, Prostate .f 1961 to 2311 363 to 13   tiling clone, AAA   351/354
(99 %)
0 diff
(100 %id)
AI865534 normal prostate, Prostate .f 1961 to 2311 353 to 2       352/359
(98 %)
0 diff
(100 %id)
R44215 whole brain .f 1979 to 2309 347 to 8       340/349
(97 %)
0 diff
(100 %id)
AW613831 2 pooled high-grade transitional celltumors, genitourinary tract .f 1992 to 2311 320 to 1       320/320
(100 %)
0 diff
(100 %id)
AI276302 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .f 2008 to 2311 304 to 1       304/304
(100 %)
0 diff
(100 %id)
CD679584 eye, Trabecular meshwork .f 2053 to 2308 1 to 256   AAA   256/256
(100 %)
1 diff
(99.7 %id)
CR600790 fetal brain .g 1 to 1782 1 to 1782 exact tiling clone,   1782/1782
(100 %)
0 diff
(100 %id)
AL535440 brain, fetal brain .g 32 to 879 33 to 878   fully sequenced,   845/877
(96 %)
14 diff
(98.5 %id)
TI_57237229   .g 33 to 729 27 to 724       698/724
(96 %)
14 diff
(98.1 %id)
BI908558 leukocyte .g 37 to 729 1 to 693       693/693
(100 %)
8 diff
(98.9 %id)
AL535439 brain, fetal brain .g 845 to 1775 938 to 8   fully sequenced,   931/938
(99 %)
0 diff
(100 %id)
BF339355 brain, glioblastoma with EGFR amplification .g 869 to 1495 1 to 629       629/629
(100 %)
11 diff
(98.3 %id)
BI519850 leukocyte .g 1101 to 1743 676 to 6       671/821
(81 %)
0 diff
(100 %id)
TI_44459985   .g 1101 to 1743 676 to 6       671/821
(81 %)
0 diff
(100 %id)
BF929249 nervous_tumor .g 1134 to 1589 20 to 475       456/475
(96 %)
6 diff
(98.8 %id)
BQ014311 Chondrosarcoma, Left Pubic Bone .g 1163 to 1801 655 to 17   tiling clone, AAA   639/639
(100 %)
0 diff
(100 %id)
BI022922 marrow .g 1188 to 1493 1 to 306       306/306
(100 %)
5 diff
(98.4 %id)
AI224114 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 1325 to 1799 475 to 1       475/475
(100 %)
2 diff
(99.6 %id)
DB521588 testis .g 1340 to 1801 1 to 464     Submitted on the opposite strand 464/464
(100 %)
2 diff
(99.6 %id)
TI_154193303   .h 1 to 876 51 to 925   tiling clone,   875/882
(99 %)
18 diff
(98.0 %id)
DR156255 human embryonic stem cells differentiated toan early endodermal cell type .h 344 to 1013 1 to 670   tiling clone,   670/670
(100 %)
0 diff
(100 %id)
BE747566 adenocarcinoma cell line, ovary .i 1 to 825 35 to 851   tiling clone,   817/1018
(80 %)
23 diff
(97.8 %id)
BG774877 carcinoma, cell line, Prostate .i 22 to 650 1 to 628   fully sequenced,   628/628
(100 %)
4 diff
(99.4 %id)
BU552615 carcinoma, cell line, Prostate .i 22 to 914 1 to 899   tiling clone,   899/902
(99 %)
8 diff
(99.2 %id)
BU542276 carcinoma, cell line, Prostate .i 25 to 822 1 to 807       807/896
(90 %)
14 diff
(98.5 %id)
BE208716 adenocarcinoma cell line, ovary .i 37 to 484 1 to 448       448/448
(100 %)
0 diff
(100 %id)
BM801366 duodenal adenocarcinoma, cell line, small intestine .i 150 to 858 1 to 715       715/1023
(69 %)
17 diff
(98.4 %id)
BC101940 PCR rescued clones .i 198 to 1685 1 to 1488 A296T tiling clone,   1488/1488
(100 %)
1 diff
(100.0 %id)
BC105637 PCR rescued clones .i 198 to 1685 1 to 1488 exact tiling clone,   1488/1488
(100 %)
1 diff
(100.0 %id)
BG775492 carcinoma, cell line, Prostate .i 589 to 1320 737 to 1   fully sequenced,   737/737
(100 %)
9 diff
(98.8 %id)
BE208345 adenocarcinoma cell line, ovary .i 872 to 1372 511 to 11   AAA   501/502
(99 %)
0 diff
(100 %id)
CR622052 fetal brain .j 1 to 1677 1 to 1677 exact tiling clone,   1677/1677
(100 %)
0 diff
(100 %id)
AL536806 brain, fetal brain .j 1 to 862 1 to 859   fully sequenced,   859/859
(100 %)
3 diff
(99.7 %id)
AL536805 brain, fetal brain .j 801 to 1640 873 to 39   fully sequenced,   835/873
(95 %)
15 diff
(98.3 %id)
TI_57238830   .k 1 to 770 22 to 794   tiling clone,   773/794
(97 %)
16 diff
(98.0 %id)
BI915561 brain .k 8 to 770 1 to 766       766/766
(100 %)
10 diff
(98.7 %id)
CR607411 fetal liver .k 11 to 1678 1 to 1668   tiling clone,   1668/1668
(100 %)
0 diff
(100 %id)
BX422287 fetal liver, Liver .k 11 to 932 1 to 916       916/1040
(88 %)
14 diff
(98.7 %id)
BI758182 brain .k 23 to 918 1 to 894       894/900
(99 %)
21 diff
(97.7 %id)
TI_57220773   .k 23 to 918 67 to 960       894/966
(92 %)
26 diff
(97.4 %id)
CR983970 T-Lymphocytes .k 25 to 674 1 to 650       650/650
(100 %)
1 diff
(99.9 %id)
CR990778 T-Lymphocytes .k 29 to 472 1 to 446       446/448
(99 %)
12 diff
(97.4 %id)
CN337731 embryonic stem cells, cell lines H1, H7, andH9 .k 36 to 768 8 to 742       735/742
(99 %)
7 diff
(99.1 %id)
CD674951 eye, lens .k 44 to 566 1 to 523       523/523
(100 %)
0 diff
(100 %id)
BX431815 fetal liver, Liver .k 773 to 1378 1 to 606       606/801
(75 %)
23 diff
(97.2 %id)
BX431816 fetal liver, Liver .k 775 to 1184 1 to 409       409/841
(48 %)
4 diff
(99.6 %id)
BF920233 nervous_tumor .k 1001 to 1239 22 to 260       239/260
(91 %)
6 diff
(97.7 %id)
BX422286 fetal liver, Liver .k 1142 to 1621 508 to 29       480/609
(78 %)
5 diff
(99.2 %id)
BM688686 eye, optic nerve .k 1227 to 1668 51 to 492   fully sequenced,   442/492
(89 %)
10 diff
(98.0 %id)
BU727054 eye, optic nerve .k 1464 to 1679 234 to 19   fully sequenced, AAA   216/216
(100 %)
1 diff
(99.6 %id)
BF685927 leiomyosarcoma cell line, uterus .l 1 to 579 1 to 579   tiling clone,   579/909
(63 %)
2 diff
(99.8 %id)
CR981251 T-Lymphocytes .l 214 to 820 1 to 607       607/610
(99 %)
1 diff
(99.9 %id)
BG469116 adenocarcinoma cell line, colon .l 237 to 684 1 to 452       452/830
(54 %)
10 diff
(98.8 %id)
CN336758 embryonic stem cells, cell lines H1, H7, andH9 .l 251 to 953 1 to 703   tiling clone,   703/703
(100 %)
0 diff
(100 %id)
BC071172 Blood, adult leukocytes .m 1 to 2190 1 to 2190 exact tiling clone, available from MGC, AAA   2190/2190
(100 %)
4 diff
(99.9 %id)
BM922728 leukocyte .m 2 to 997 1 to 1008   available from MGC,   1008/1019
(98 %)
31 diff
(97.0 %id)
BM152832 leukopheresis .m 717 to 1129 12 to 424       413/424
(97 %)
7 diff
(98.4 %id)
BE246616 leukopheresis .m 719 to 1109 35 to 427       393/427
(92 %)
15 diff
(96.5 %id)
AK023553 placenta .n 1 to 2079 2 to 2080 exact tiling clone, available from FLJ,   2080/2080
(100 %)
3 diff
(99.9 %id)
NM_024623.1   .n 1 to 2079 2 to 2080 exact RefSeq,   2080/2080
(100 %)
3 diff
(99.9 %id)
AU136439 placenta .n 1 to 734 2 to 742   capped   739/798
(92 %)
14 diff
(98.3 %id)
CN299698 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 48 to 338 1 to 291       291/291
(100 %)
0 diff
(100 %id)
CR457316   .n 512 to 1380 1 to 869       869/873
(99 %)
1 diff
(99.9 %id)
AU156723 placenta .n 1534 to 2079 545 to 1       545/545
(100 %)
17 diff
(96.9 %id)
BI871123 adenocarcinoma, cell line, Liver .o 1 to 887 1 to 897 A44R P45L Q46S S47L G48E ... tiling clone,   893/897
(99 %)
29 diff
(96.8 %id)
TI_57230334   .o 1 to 887 92 to 988 A44R P45L Q46S S47L G48E ...     893/897
(99 %)
29 diff
(96.8 %id)
CD580469 brain .p 1 to 850 1 to 852 R12C A36S G129V A258T A263G ... tiling clone,   852/909
(93 %)
12 diff
(98.7 %id)
BI252119 hepatocellular carcinoma, cell line, Liver .q 1 to 432 1 to 434   tiling clone,   434/803
(54 %)
11 diff
(98.7 %id)
BQ643520 hepatocellular carcinoma, cell line, Liver .q 3 to 801 1 to 806   tiling clone,   806/825
(97 %)
15 diff
(98.2 %id)
BQ647333 hepatocellular carcinoma, cell line, Liver .q 3 to 912 1 to 915   tiling clone,   915/917
(99 %)
22 diff
(97.7 %id)
BM904219 lymph, lymphoma, cell line .r 1 to 791 1 to 797 Q225R A226H T228Q A229P L230* tiling clone,   797/1048
(76 %)
17 diff
(98.4 %id)
CX870403 embryonic stem .s 1 to 669 1 to 669   tiling clone,   669/669
(100 %)
0 diff
(100 %id)
DN994077 brain, whole brain .s 256 to 685 9 to 438       430/438
(98 %)
6 diff
(98.7 %id)
CN275316 embryonic stem cells, DMSO-treated H9 cellline .s 585 to 1120 9 to 545   tiling clone,   537/545
(98 %)
7 diff
(98.8 %id)
BQ051930 blood, natural killer cells, cell line .t 1 to 545 1 to 552   tiling clone,   552/1314
(42 %)
30 diff
(97.8 %id)
BQ051835 blood, natural killer cells, cell line .t 3 to 772 1 to 771 F115L I116L E140D A152S I158M ... tiling clone,   771/1034
(74 %)
43 diff
(95.9 %id)
CT003672 T-Lymphocytes .u 1 to 812 6 to 812 K94R S140I A141S G142W E143G ... tiling clone,   812/825
(98 %)
9 diff
(99.0 %id)
BF308812 muscle, rhabdomyosarcoma .u 1 to 730 3 to 735       735/928
(79 %)
46 diff
(95.1 %id)
BF725773 eye, Iris .u 21 to 541 1 to 521       521/521
(100 %)
0 diff
(100 %id)
BF971719 leiomyosarcoma cell line, uterus .u 24 to 747 1 to 730   tiling clone,   730/939
(77 %)
18 diff
(98.1 %id)
BG393388 embryonal carcinoma, cell line, testis .u 24 to 810 1 to 779   tiling clone,   779/779
(100 %)
16 diff
(98.0 %id)
BI257265 cervical carcinoma cell line, cervix .u 40 to 834 24 to 823 S85I S86L S87L S88F S89L ... tiling clone,   800/827
(96 %)
46 diff
(94.5 %id)
BM050318 eye, normal pigmented retinal epithelium .u 45 to 440 1 to 396       396/830
(47 %)
8 diff
(99.1 %id)
CR988345 T-Lymphocytes .u 46 to 663 1 to 618   tiling clone,   618/618
(100 %)
0 diff
(100 %id)
BQ653070 hepatocellular carcinoma, cell line, Liver .va 1 to 717 25 to 747 I173H R174P K175Q V176G V177G ... tiling clone,   728/1004
(72 %)
36 diff
(96.5 %id)
EU624491   .vb 1 to 1318 1 to 1318 exact tiling clone, AAA   1318/1318
(100 %)
0 diff
(100 %id)
TI_44344592   .vc 1 to 716 80 to 795       720/795
(90 %)
11 diff
(98.7 %id)
BI670145 brain, hypothalamus .vc 1 to 630 1 to 630   tiling clone,   630/630
(100 %)
6 diff
(99.1 %id)
CV805116 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .vc 86 to 792 1 to 705       705/729
(96 %)
14 diff
(98.1 %id)
DN992667 brain, whole brain .vc 147 to 692 1 to 547       547/547
(100 %)
10 diff
(98.2 %id)
BU552522 carcinoma, cell line, Prostate .vc 162 to 1056 1 to 903 exact tiling clone,   903/903
(100 %)
9 diff
(99.1 %id)
BQ943601 carcinoma, cell line, Prostate .vc 164 to 1007 1 to 842 exact     842/927
(90 %)
10 diff
(99.0 %id)
DB495434 hypothalamus .vd 1 to 509 3 to 511   tiling clone,   511/511
(100 %)
1 diff
(99.9 %id)
BG704117 brain, hippocampus .vd 2 to 646 1 to 646       646/649
(99 %)
6 diff
(99.1 %id)
AI890501 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .vd 16 to 432 1 to 418     Submitted on the opposite strand 418/418
(100 %)
2 diff
(99.6 %id)
BF339114 brain, glioblastoma with EGFR amplification .vd 17 to 783 1 to 762 K98T R99E K100E K101E L102A ...     762/1102
(69 %)
13 diff
(98.9 %id)
CR612958 Neuroblastoma Cot 25-normalized .vd 20 to 1004 1 to 985 exact tiling clone,   985/985
(100 %)
0 diff
(100 %id)
BX375202 Neuroblastoma Cot 25-normalized .vd 20 to 999 1 to 976 G120X S145X fully sequenced,   976/976
(100 %)
11 diff
(98.9 %id)
BG117300 adenocarcinoma, cell line, Liver .vd 22 to 782 9 to 757 R146E I147S Q148R A149H M150E ...     750/840
(89 %)
25 diff
(97.1 %id)
BG113817 Bone, osteosarcoma, cell line .vd 80 to 876 1 to 803 K94N K95E K96E K97E K98E ...     801/926
(86 %)
52 diff
(94.4 %id)
BX350998 Neuroblastoma Cot 25-normalized .vd 619 to 981 366 to 5   fully sequenced,   362/366
(98 %)
0 diff
(100 %id)
CR626482 B cells (Ramos cell line) Cot 25-normalized .ve 1 to 1273 1 to 1273 exact tiling clone,   1273/1273
(100 %)
0 diff
(100 %id)
BX385580   .ve 1 to 703 1 to 703   fully sequenced,   703/703
(100 %)
6 diff
(99.2 %id)
DA399111 thalamus .ve 209 to 771 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BU858218 adenocarcinoma, cell line, breast .ve 228 to 905 31 to 714       684/929
(73 %)
20 diff
(97.9 %id)
CA868051 Pancreas, Purified pancreatic islet .ve 333 to 847 1 to 515   fully sequenced,   515/515
(100 %)
0 diff
(100 %id)
BE562309 Burkitt lymphoma, lymph .ve 392 to 1272 30 to 901 K180T     872/902
(96 %)
32 diff
(96.5 %id)
BI227310 Burkitt lymphoma, lymph .ve 392 to 935 46 to 595       550/597
(92 %)
31 diff
(94.9 %id)
BE561699 Burkitt lymphoma, lymph .ve 394 to 1229 38 to 867 S39P T40H S41P Q42K E43R ...     830/931
(89 %)
20 diff
(97.9 %id)
BX385579   .ve 673 to 1273 601 to 1   fully sequenced,   601/601
(100 %)
11 diff
(98.2 %id)
CA868300 Pancreas, Purified pancreatic islet .ve 801 to 1309 512 to 4   tiling clone, fully sequenced,   509/512
(99 %)
0 diff
(100 %id)
AF267748 lung .vf 1 to 889 1 to 888 K149N L150* tiling clone, AAA   888/888
(100 %)
9 diff
(99.0 %id)
CB128843 Liver .vg 1 to 627 1 to 627   tiling clone,   627/627
(100 %)
2 diff
(99.7 %id)
CB116913 Liver .vg 1 to 527 1 to 527   tiling clone,   527/527
(100 %)
2 diff
(99.7 %id)
TI_149314196   .vg 52 to 1006 1028 to 82   tiling clone, AAA   947/1002
(94 %)
13 diff
(98.8 %id)
CB305888 lung, Primary Lung Cystic Fibrosis EpithelialCells .vg 322 to 1006 702 to 19   tiling clone, AAA   684/684
(100 %)
1 diff
(99.9 %id)
CB994415 placenta, pre-eclamptic placenta .vh 1 to 719 28 to 760 L162P Q163A P164A L165A M166D ... tiling clone,   733/848
(86 %)
31 diff
(96.4 %id)
CB994935 placenta, pre-eclamptic placenta .vh 1 to 614 28 to 642   tiling clone,   615/685
(89 %)
8 diff
(98.9 %id)
CB991294 placenta, pre-eclamptic placenta .vh 2 to 426 29 to 453       425/476
(89 %)
7 diff
(98.6 %id)
BM909804 astrocytoma grade IV, cell line, brain .vi 1 to 799 1 to 805 K166X E167G E168G W169V D170G ... tiling clone,   805/1092
(73 %)
9 diff
(99.2 %id)
BG765065 melanotic melanoma, high MDR (cell line), skin .vj 1 to 625 6 to 635 K128E K129G K131G K132R L133G ... tiling clone,   635/746
(85 %)
24 diff
(96.8 %id)
BJ995564 hepatoblastoma .vk 1 to 435 1 to 435   tiling clone,   435/435
(100 %)
0 diff
(100 %id)
DB038383 testis .vk 7 to 575 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DB494277 hypothalamus .vk 8 to 508 1 to 501       501/501
(100 %)
0 diff
(100 %id)
DB498937 hypothalamus .vk 8 to 506 1 to 499       499/499
(100 %)
1 diff
(99.8 %id)
BM560177 brain, medulla .vk 17 to 840 20 to 848   tiling clone,   829/1029
(80 %)
23 diff
(97.8 %id)
BI909652 leukocyte .vk 18 to 821 1 to 806   tiling clone,   806/806
(100 %)
6 diff
(99.3 %id)
TI_57234888   .vk 18 to 821 34 to 839       806/839
(96 %)
12 diff
(98.6 %id)
BF347460 anaplastic oligodendroglioma with 1p/19qloss, brain .vk 23 to 849 1 to 829   tiling clone,   829/859
(96 %)
31 diff
(96.4 %id)
BJ995565 hepatoblastoma .vk 1237 to 1734 498 to 1   tiling clone,   498/498
(100 %)
0 diff
(100 %id)
AL543072.
matches multiple genes
placenta, Placenta Cot 25-normalized .vl 1 to 1029 1 to 1007 S48T R49E G50A C51V V52L ... tiling clone, also hits gene MUL1 1007/1066
(94 %)
16 diff
(98.5 %id)
AL569751.
matches multiple genes
placenta, Placenta Cot 25-normalized .vl 1599 to 2611 999 to 1   tiling clone, also hits gene MUL1 999/1045
(95 %)
20 diff
(98.1 %id)
BI910394 leukocyte .vl 1700 to 2494 1 to 795   tiling clone,   795/796
(99 %)
5 diff
(99.4 %id)
TI_57235947   .vl 1700 to 2494 34 to 828       795/829
(95 %)
11 diff
(98.7 %id)
BI910789 leukocyte .vm 1 to 809 1 to 805 P4T L137* tiling clone,   805/805
(100 %)
6 diff
(99.3 %id)
TI_57237540   .vm 1 to 809 32 to 836 P4T L137*     805/836
(96 %)
11 diff
(98.7 %id)
BP363956 lung .vn 1 to 582 1 to 582 exact tiling clone,   582/582
(100 %)
0 diff
(100 %id)
TI_154130873   .vo 1 to 812 904 to 94 A5L H6T V7S G8A S9P ... tiling clone, AAA   811/974
(83 %)
19 diff
(98.1 %id)
TI_149306649   .vo 2 to 814 894 to 89 A5L H6T V7R G8S S9R ... tiling clone, AAA   806/956
(84 %)
20 diff
(98.0 %id)
TI_149276188   .vo 56 to 814 840 to 88   tiling clone, AAA   753/953
(79 %)
12 diff
(98.8 %id)
BM968937 lung, Primary Lung Epithelial Cells .vo 182 to 814 650 to 17   tiling clone, AAA   634/634
(100 %)
2 diff
(99.7 %id)
DB505196 hypothalamus .vp 1 to 463 1 to 463   tiling clone,   463/463
(100 %)
2 diff
(99.6 %id)
TI_149307716   .vp 139 to 916 861 to 89   tiling clone, AAA   773/945
(81 %)
10 diff
(99.0 %id)
BM979445 lung, Primary Lung Epithelial Cells .vp 272 to 916 661 to 17   AAA   645/645
(100 %)
0 diff
(100 %id)
BM718468 eye, fetal eye .vq 1 to 436 1 to 436   tiling clone, fully sequenced,   436/436
(100 %)
0 diff
(100 %id)
BM683512 eye, fetal eye .vq 406 to 996 609 to 19   tiling clone, fully sequenced, AAA   591/591
(100 %)
0 diff
(100 %id)
BG682871 brain, neuroblastoma, cell line .vr 1 to 694 1 to 697   tiling clone, available from MGC,   697/708
(98 %)
8 diff
(98.9 %id)
BC015605 Brain, neuroblastoma .vr 2 to 1696 1 to 1695 exact tiling clone, available from MGC, AAA   1695/1695
(100 %)
2 diff
(99.9 %id)
BQ068904 brain, neuroblastoma, cell line .vr 3 to 805 1 to 812       812/988
(82 %)
9 diff
(99.1 %id)
TI_44349199   .vs 1 to 821 86 to 913 K118R E119R K120R A121R E122K ... tiling clone,   832/1059
(78 %)
22 diff
(98.0 %id)
BI560794 testis .vs 2 to 821 1 to 827 K118R E119R K120R A121R E122K ...     827/858
(96 %)
16 diff
(98.2 %id)
BU949967 Pancreas, Purified pancreatic islet .vs 3 to 502 1 to 504   fully sequenced,   500/500
(100 %)
0 diff
(100 %id)
CD672894 eye, Iris .vs 6 to 535 1 to 530       530/530
(100 %)
0 diff
(100 %id)
CA866709 Pancreas, Purified pancreatic islet .vs 43 to 572 1 to 530   fully sequenced,   530/530
(100 %)
0 diff
(100 %id)
DQ099385   .vs 53 to 598 1 to 546 exact     546/546
(100 %)
0 diff
(100 %id)
AA676365   .vs 175 to 635 1 to 457     Submitted on the opposite strand 458/457
(100 %)
13 diff
(97.2 %id)
CA417916 Bone, Human Chondrosarcoma Cell Line .vs 237 to 829 609 to 17   tiling clone, AAA   593/593
(100 %)
1 diff
(99.9 %id)
CB851370 lung, Primary Lung Epithelial Cells .vs 267 to 831 581 to 17   AAA   565/565
(100 %)
4 diff
(99.3 %id)
BU949679 Pancreas, Purified pancreatic islet .vs 441 to 830 391 to 2   fully sequenced,   390/391
(99 %)
0 diff
(100 %id)
CA866966 Pancreas, Purified pancreatic islet .vs 511 to 830 323 to 4   fully sequenced,   320/323
(99 %)
0 diff
(100 %id)
BC047676 Testis, embryonal carcinoma .vt 1 to 1464 1 to 1464 exact tiling clone, available from MGC, AAA   1464/1464
(100 %)
0 diff
(100 %id)
BF229851 colon_est .vt 551 to 920 1 to 366       366/380
(96 %)
9 diff
(97.7 %id)
AK303095 thymus .vu 1 to 1039 1 to 1039 exact tiling clone,   1039/1039
(100 %)
0 diff
(100 %id)
DC404984 thymus .vu 1 to 554 1 to 554 exact     554/554
(100 %)
0 diff
(100 %id)
BP351012   .vu 8 to 590 1 to 583 exact     583/583
(100 %)
0 diff
(100 %id)
BM700435 eye, lens .vv 1 to 497 1 to 497   tiling clone,   497/497
(100 %)
0 diff
(100 %id)
CD671917 eye, Iris .vv 19 to 633 1 to 615 S14I tiling clone,   615/615
(100 %)
1 diff
(99.9 %id)
AA313353 colon .vv 84 to 565 1 to 482       482/482
(100 %)
0 diff
(100 %id)
BP385809 pancreatic islet .vv 98 to 596 499 to 1       499/500
(99 %)
0 diff
(100 %id)
CB129995 Liver .vw 1 to 609 1 to 609 exact tiling clone,   609/609
(100 %)
0 diff
(100 %id)
TI_57177519   .vx 1 to 901 28 to 935 exact tiling clone,   908/939
(96 %)
31 diff
(96.7 %id)
BI766561 pooled lung and spleen .vx 4 to 901 1 to 905 exact tiling clone,   905/909
(99 %)
25 diff
(97.3 %id)
DA665818   .vy 1 to 514 2 to 515 L157I tiling clone, capped   514/514
(100 %)
2 diff
(99.7 %id)
AI299499 carcinoid, lung .vz 1 to 426 4 to 429     Submitted on the opposite strand 429/429
(100 %)
1 diff
(99.8 %id)
BG721722 testis .vz 2 to 789 1 to 787 exact tiling clone,   787/787
(100 %)
13 diff
(98.4 %id)
BG751373 eye, normal pigmented retinal epithelium .vz 4 to 735 1 to 740 K96N K97E K98E K100G K101R ... tiling clone,   740/898
(82 %)
16 diff
(98.3 %id)
TI_149305273   .vz 40 to 796 847 to 94 A2S H3R V4R G5S S6R ... AAA   754/922
(81 %)
7 diff
(99.3 %id)
BI713047 Pancreas, Purified pancreatic islet .vz 42 to 469 1 to 432   fully sequenced,   428/428
(100 %)
0 diff
(100 %id)
BU685645 lung, Primary Lung Epithelial Cells .vz 116 to 796 697 to 17   AAA   681/681
(100 %)
1 diff
(99.9 %id)
DB568698 hypothalamus .vz 309 to 797 1 to 489     Submitted on the opposite strand 489/490
(99 %)
1 diff
(99.8 %id)
AW512961 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .vz 311 to 798 496 to 9       488/496
(98 %)
0 diff
(100 %id)
BM687607 eye, eye anterior segment .vz 326 to 798 1 to 471       471/471
(100 %)
7 diff
(98.6 %id)
AI991302 colon, colonic mucosa from 3 patients with Crohn'sdisease .vz 334 to 798 469 to 1   tiling clone,   465/469
(99 %)
0 diff
(100 %id)
BQ278869 adenocarcinoma, cell line, breast .vz 391 to 796 1 to 406   AAA   406/406
(100 %)
1 diff
(99.8 %id)
AA643064 epithelium (cell line), Prostate .vz 392 to 798 409 to 4       406/409
(99 %)
0 diff
(100 %id)
AA836782 Kidney, kidney tumor .vz 392 to 796 419 to 16   AAA   404/404
(100 %)
3 diff
(99.3 %id)
AA575985 breast, breast tumor .vz 393 to 796 402 to 1       402/402
(100 %)
8 diff
(98.1 %id)
BI712095 Pancreas, Purified pancreatic islet .vz 408 to 798 396 to 4   fully sequenced,   393/396
(99 %)
0 diff
(100 %id)
CN336762 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .wa 1 to 455 1 to 455   tiling clone,   455/455
(100 %)
2 diff
(99.6 %id)
BG707080 brain, hypothalamus .wa 10 to 766 1 to 758 K109N A110G E111G A112S Q113T ... tiling clone,   758/758
(100 %)
10 diff
(98.7 %id)
BG706697 brain, hypothalamus .wa 10 to 611 1 to 602   tiling clone,   602/604
(99 %)
8 diff
(98.7 %id)
BG716044 brain, hypothalamus .wa 10 to 716 1 to 725 K8*     725/725
(100 %)
32 diff
(95.6 %id)
BI667920 brain, hypothalamus .wa 10 to 832 1 to 819 K98T tiling clone,   819/820
(99 %)
22 diff
(97.4 %id)
BI670459 brain, hypothalamus .wa 10 to 770 1 to 761 L168V L169A P170S tiling clone,   761/761
(100 %)
11 diff
(98.6 %id)
DB497599 hypothalamus .wa 15 to 524 1 to 510       510/510
(100 %)
1 diff
(99.9 %id)
TI_44343877   .wa 15 to 832 91 to 904 K98T     814/905
(89 %)
21 diff
(97.7 %id)
TI_44345414   .wa 15 to 770 87 to 842 L168V L169A P170S     756/842
(89 %)
10 diff
(98.9 %id)
BG569916 lung .wa 19 to 141 1 to 123       123/123
(100 %)
1 diff
(99.2 %id)
BE728399 melanotic melanoma, skin .wa 58 to 847 1 to 762 C36A S37R A38L S39Q T40S ... tiling clone, AAA   767/892
(85 %)
46 diff
(94.9 %id)
BG745397 Spleen .wb 1 to 367 1 to 368   tiling clone, fully sequenced, AAA   368/368
(100 %)
4 diff
(99.0 %id)
BG746217 Spleen .wb 337 to 809 473 to 3   tiling clone, fully sequenced,   471/473
(99 %)
0 diff
(100 %id)
AA625305 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .wc 1 to 496 1 to 498 P35Q G36A Q66R S67A R68G ... tiling clone,   494/498
(99 %)
5 diff
(99.0 %id)
CN336767 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .wd 1 to 486 1 to 486 exact tiling clone,   486/486
(100 %)
0 diff
(100 %id)
DB459089 testis .we 1 to 479 1 to 479 N20X tiling clone,   479/479
(100 %)
0 diff
(100 %id)
BM793930 Ascites, stomach .we 186 to 871 1 to 686   tiling clone,   686/686
(100 %)
1 diff
(99.9 %id)
BE273453 Kidney, renal cell adenocarcinoma .wf 1 to 797 1 to 794 exact tiling clone,   794/796
(99 %)
6 diff
(99.3 %id)
BM824758 Ascites, stomach .wf 591 to 1073 1 to 483   tiling clone,   483/483
(100 %)
0 diff
(100 %id)
BC009181 Skin, melanotic melanoma. .wg 1 to 1619 9 to 1627 exact tiling clone, available from MGC, AAA   1619/1619
(100 %)
1 diff
(100.0 %id)
BG475764 melanotic melanoma, skin .wg 1 to 402 1 to 403       403/897
(44 %)
4 diff
(99.6 %id)
BM808167 ovary (pool of 3) .wg 12 to 725 12 to 725       714/1100
(64 %)
26 diff
(97.7 %id)
BF026010 melanotic melanoma, skin .wg 21 to 802 1 to 773 R18G S19A I20S L22S R23A ... available from MGC,   773/774
(99 %)
20 diff
(97.5 %id)
DB447440 testis .wg 24 to 439 1 to 415       415/415
(100 %)
2 diff
(99.6 %id)
BX494599 Liver .wg 55 to 364 1 to 310       310/310
(100 %)
3 diff
(99.1 %id)
DB455528 testis .wg 56 to 518 1 to 463       463/463
(100 %)
1 diff
(99.8 %id)
DA749959   .wg 57 to 619 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BE548061 cervical carcinoma cell line, cervix .wg 94 to 808 1 to 709 P79L E80R V81S Y82T D83T ...     709/856
(82 %)
21 diff
(97.6 %id)
BC098119 PCR rescued clones .wg 269 to 1949 1 to 1681 exact     1681/1681
(100 %)
1 diff
(100.0 %id)
BC098293 PCR rescued clones .wg 269 to 1949 1 to 1681 exact tiling clone,   1681/1681
(100 %)
0 diff
(100 %id)
BG683585 brain, neuroblastoma, cell line .wg 870 to 1552 708 to 23   available from MGC,   686/708
(96 %)
4 diff
(99.5 %id)
BM793735 Ascites, stomach .wh 1 to 541 1 to 541 Q125H tiling clone,   541/541
(100 %)
1 diff
(99.9 %id)
CR991128 T-Lymphocytes .wi 1 to 543 1 to 545 R4S R5K R6V G7R A8G ... tiling clone,   545/587
(92 %)
6 diff
(99.0 %id)
CR994937 T-Lymphocytes .wj -8 to 707 1 to 716 exact tiling clone,   716/716
(100 %)
1 diff
(99.9 %id)
CR610399 Placenta Cot 25-normalized .wk 1 to 1341 1 to 1341 exact tiling clone,   1341/1341
(100 %)
0 diff
(100 %id)
BX339148 Placenta Cot 25-normalized .wk 1 to 684 1 to 685 S48T R49E G50A C51V V52L ... fully sequenced,   685/685
(100 %)
8 diff
(98.9 %id)
BX339147 Placenta Cot 25-normalized .wk 624 to 1303 727 to 38   fully sequenced,   690/727
(94 %)
0 diff
(100 %id)
BC033857 Cervix, carcinoma .wl 1 to 1480 12 to 1491 exact tiling clone, available from MGC, AAA   1480/1480
(100 %)
1 diff
(100.0 %id)
BI258499 cervical carcinoma cell line, cervix .wl 1 to 835 1 to 837 L97* available from MGC,   837/838
(99 %)
16 diff
(98.1 %id)
BE540517 cervix .wm 1 to 491 1 to 490 L96W E97R T98H tiling clone,   757/888
(85 %)
22 diff
(97.6 %id)
DA967054 stomach .wn 1 to 569 3 to 571   tiling clone, capped   570/570
(100 %)
0 diff
(100 %id)
AK095481   .wn 67 to 1954 1 to 1888 N80S tiling clone, available from FLJ,   1888/1888
(100 %)
4 diff
(99.8 %id)
DA474622   .wn 68 to 605 2 to 542   capped   541/541
(100 %)
4 diff
(99.3 %id)
BF155300 breast .wn 417 to 925 1 to 508       508/530
(95 %)
8 diff
(98.5 %id)
R90861 brain .wn 460 to 875 1 to 424       424/446
(95 %)
15 diff
(96.7 %id)
H51019 brain .wn 461 to 788 1 to 328       328/329
(99 %)
5 diff
(98.5 %id)
CD632167   .wn 584 to 946 1 to 364       364/376
(96 %)
6 diff
(98.5 %id)
CD632168   .wn 590 to 946 369 to 12       358/375
(95 %)
0 diff
(100 %id)
TI_57202076   .wn 597 to 1347 25 to 777 C183X A184C L185A T186H *187L AAA   753/777
(96 %)
12 diff
(98.5 %id)
BU509220 leiomyosarcoma, uterus .wn 606 to 1419 1 to 825       825/871
(94 %)
21 diff
(97.6 %id)
TI_149290804   .wn 610 to 1348 829 to 92 P2X K3R R5A P6Q N7H ... AAA   738/982
(75 %)
5 diff
(99.5 %id)
TI_159696408   .wn 654 to 1348 732 to 39 P2A K3* AAA   694/1012
(68 %)
10 diff
(99.1 %id)
BU615672 cell lines, Chondrosarcoma .wn 666 to 1360 711 to 19 P2X R5G N7T T8P M9* AAA   693/693
(100 %)
1 diff
(99.9 %id)
BU634113 cell lines, Chondrosarcoma .wn 667 to 1348 700 to 19 R136H AAA   682/682
(100 %)
2 diff
(99.8 %id)
CA424924 cell lines, Chondrosarcoma .wn 684 to 1348 681 to 19 P2X R5G N7T T8P M9* AAA   663/663
(100 %)
3 diff
(99.6 %id)
CA422669 cell lines, Chondrosarcoma .wn 720 to 1360 662 to 19   AAA   644/644
(100 %)
4 diff
(99.4 %id)
BU621404 cell lines, Chondrosarcoma .wn 720 to 1360 659 to 19   AAA   641/641
(100 %)
0 diff
(100 %id)
BQ772538 Chondrosarcoma Cell line .wn 735 to 1348 633 to 19   AAA   615/628
(97 %)
4 diff
(99.4 %id)
BU681866 lung .wn 744 to 1348 624 to 19   AAA   606/606
(100 %)
1 diff
(99.9 %id)
BU620164 cell lines, Chondrosarcoma .wn 759 to 1348 608 to 19   AAA   590/590
(100 %)
3 diff
(99.5 %id)
AI309636 2 pooled tumors (clear cell type), Kidney .wn 805 to 1362 561 to 4   tiling clone,   558/561
(99 %)
0 diff
(100 %id)
AI431902 Kidney .wn 805 to 1360 566 to 11   AAA   556/556
(100 %)
2 diff
(99.7 %id)
AI569285 anaplastic oligodendroglioma, brain .wn 805 to 1343 556 to 18   AAA   539/539
(100 %)
4 diff
(99.3 %id)
BF060999 pooled .wn 814 to 1362 553 to 5       549/553
(99 %)
0 diff
(100 %id)
AI740858 pooled .wn 840 to 1358 536 to 21   AAA   516/527
(97 %)
8 diff
(98.5 %id)
AW469951 2 pooled tumors (clear cell type), Kidney .wn 842 to 1144 303 to 1       303/316
(95 %)
15 diff
(95.3 %id)
BU622636 cell lines, Chondrosarcoma .wn 852 to 1348 515 to 19   AAA   497/497
(100 %)
2 diff
(99.6 %id)
CA420470 Bone, Enchondroma cell line .wn 879 to 1367 507 to 19   AAA   489/489
(100 %)
4 diff
(99.2 %id)
AI025662 parathyroid gland, parathyroid tumor .wn 890 to 1362 477 to 5       473/481
(98 %)
3 diff
(99.4 %id)
BM552691 brain, medulla .wn 903 to 1360 1 to 458       458/531
(86 %)
1 diff
(99.9 %id)
AI538588 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .wn 916 to 1359 482 to 38   AAA   445/445
(100 %)
25 diff
(94.4 %id)
R85499 brain .wn 928 to 1345 439 to 16       424/492
(86 %)
8 diff
(98.4 %id)
AI082157   .wn 931 to 1362 437 to 6       432/437
(98 %)
0 diff
(100 %id)
AW294963   .wn 959 to 1348 407 to 18   AAA   390/400
(97 %)
0 diff
(100 %id)
H41492 brain .wn 965 to 1321 360 to 1       360/360
(100 %)
4 diff
(98.9 %id)
EC556383 Prostate .wn 979 to 1078 99 to 1       99/106
(93 %)
0 diff
(100 %id)
AA699608 liver and spleen .wn 1005 to 1348 344 to 1       344/344
(100 %)
0 diff
(100 %id)
AL577870 placenta .wn 1020 to 1924 906 to 1       906/906
(100 %)
15 diff
(98.4 %id)
R90840 brain .wn 1034 to 1349 328 to 11       318/328
(96 %)
6 diff
(98.2 %id)
AA884835 pooled .wn 1046 to 1348 316 to 14   AAA   303/303
(100 %)
0 diff
(100 %id)
H51020 brain .wn 1053 to 1359 311 to 3       309/311
(99 %)
0 diff
(100 %id)
AW873725 adrenal gland, neuroblastoma .wn 1062 to 1361 300 to 1       300/300
(100 %)
0 diff
(100 %id)
AI950102 2 pooled tumors (clear cell type), Kidney .wn 1064 to 1349 290 to 5       286/290
(98 %)
0 diff
(100 %id)
AA741217 2 pooled tumors (clear cell type), Kidney .wn 1085 to 1362 281 to 4       278/281
(98 %)
0 diff
(100 %id)
AI700936 Kidney .wn 1110 to 1344 236 to 2       235/236
(99 %)
0 diff
(100 %id)
CU451057 epidermis .wn 1139 to 1900 773 to 12     Submitted on the opposite strand 762/773
(98 %)
0 diff
(100 %id)
TI_149299080   .wn 1162 to 1955 879 to 91   AAA   789/952
(82 %)
9 diff
(99.1 %id)
BQ574990 Chondrosarcoma Grade II, Left Pelvis .wn 1183 to 1952 784 to 19   AAA   766/766
(100 %)
4 diff
(99.5 %id)
BM975557 lung, Primary Lung Cystic Fibrosis EpithelialCells .wn 1197 to 1955 775 to 19   tiling clone, AAA   757/757
(100 %)
2 diff
(99.8 %id)
BM929709 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .wn 1215 to 1745 1 to 531       531/531
(100 %)
7 diff
(98.7 %id)
BM929711 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .wn 1215 to 1949 1 to 735       735/735
(100 %)
5 diff
(99.4 %id)
BM708253 eye, RPE and Choroid .wn 1235 to 1418 1 to 181   fully sequenced,   181/181
(100 %)
1 diff
(99.5 %id)
EL950494 eyeball .wn 1320 to 1794 19 to 493       475/493
(96 %)
6 diff
(98.8 %id)
CA438975 lung, Lung Focal Fibrosis .wn 1356 to 1949 612 to 19   AAA   594/594
(100 %)
3 diff
(99.5 %id)
BU731341 eye, RPE and Choroid .wn 1388 to 1952 583 to 19   fully sequenced, AAA   565/565
(100 %)
1 diff
(99.9 %id)
AW084809 esophagus, squamous cell carcinoma .wn 1706 to 1952 269 to 23   AAA   247/247
(100 %)
5 diff
(98.0 %id)
AL528806 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .wo 1 to 895 1 to 884   tiling clone,   884/944
(93 %)
17 diff
(98.2 %id)
BP370387 testis .wo 14 to 572 1 to 558       558/558
(100 %)
6 diff
(99.0 %id)
BP343061 stomach mucosa .wo 16 to 597 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DB046761 testis .wo 19 to 587 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
CV807455 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .wo 26 to 737 1 to 712       712/712
(100 %)
0 diff
(100 %id)
DB113404 thymus .wo 27 to 605 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA262206 caudate nucleus .wo 28 to 588 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BE743817 adenocarcinoma cell line, ovary .wo 28 to 628 1 to 607       607/808
(75 %)
17 diff
(97.9 %id)
BG743998 blood, natural killer cells, cell line .wo 162 to 653 1 to 493   fully sequenced,   493/493
(100 %)
3 diff
(99.4 %id)
BQ053780 blood, natural killer cells, cell line .wo 165 to 1116 24 to 983   tiling clone,   960/983
(97 %)
29 diff
(97.1 %id)
BQ054027 blood, natural killer cells, cell line .wo 167 to 908 34 to 782       749/1125
(66 %)
21 diff
(98.2 %id)
BG744662 blood, natural killer cells, cell line .wo 592 to 1286 695 to 3 L108W E109R V110W E111S H112T ... tiling clone, fully sequenced,   693/695
(99 %)
2 diff
(99.8 %id)
AL563252 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .wo 903 to 1893 974 to 1   tiling clone,   974/1028
(94 %)
21 diff
(98.0 %id)
BX640734 human fetal liver .wp 1 to 1827 1 to 1825 W123A P125E S126F S127L W128A ... tiling clone, available from DKFZ, AAA   1825/1825
(100 %)
5 diff
(99.8 %id)
BI822879 pooled brain, lung, testis .wp 483 to 1225 1 to 745   tiling clone, AAA   745/745
(100 %)
7 diff
(99.1 %id)
CR622109 HeLa cells Cot 25-normalized .wq 1 to 1568 1 to 1568 exact tiling clone,   1568/1568
(100 %)
0 diff
(100 %id)
AL555342 placenta .wq 1 to 863 1 to 862 S33T R34E G35A C36V V37L ...     862/862
(100 %)
4 diff
(99.6 %id)
DR004628 placenta .wq 35 to 640 1 to 605 exact     605/605
(100 %)
6 diff
(99.1 %id)
BX350517   .wq 698 to 1552 852 to 1       852/852
(100 %)
31 diff
(96.4 %id)
BX390735   .wq 720 to 1497 1 to 781       781/868
(89 %)
26 diff
(97.1 %id)
AK027285 whole embryo, mainly head .wr 1 to 1369 2 to 1371   tiling clone, available from FLJ,   1371/1371
(100 %)
5 diff
(99.7 %id)
DA568919 whole embryo, mainly head .wr 1 to 792 2 to 794   capped   793/799
(99 %)
10 diff
(98.8 %id)
DB355494 whole embryo, mainly head .wr 807 to 1369 564 to 1 T5P E7X D10N tiling clone,   564/566
(99 %)
6 diff
(99.0 %id)
DA068355 cerebellum .ws 1 to 575 2 to 576   tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
DA541501 lung .wt-u 1 to 573 2 to 571 G43X V45G S46E G47W R48P ... tiling clone, capped   570/570
(100 %)
3 diff
(99.5 %id)
DB473078 hippocampus .wt-u 2 to 472 1 to 471 exact tiling clone,   471/471
(100 %)
2 diff
(99.6 %id)
CN283750 embryonic stem cells, cell lines H1, H7, andH9 .wt-u 26 to 350 1 to 325       325/325
(100 %)
2 diff
(99.4 %id)
DB075798 testis .wu 1 to 547 2 to 548   tiling clone, capped   547/547
(100 %)
0 diff
(100 %id)
88 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg, .vh, .vi, .vj, .vk, .vl, .vm, .vn, .vo, .vp, .vq, .vr, .vs, .vt, .vu, .vv, .vw, .vx, .vy, .vz, .wa, .wb, .wc, .wd, .we, .wf, .wg, .wh, .wi, .wj, .wk, .wl, .wm, .wn, .wo, .wp, .wq, .wr, .ws, .wt-u, .wu Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI